{
    "abstract": " We reported previously that a synthetic mucosal adjuvant SF-10, which mimics human pulmonary surfactant, delivers antigen to mucosal dendritic cells in the nasal cavity and promotes induction of humoral and cellular immunity. The aim of the present study was to determine the effects of oral administration of antigen combined with SF-10 (antigen-SF-10) on systemic and local immunity. Oral administration of ovalbumin, a model antigen, combined with SF-10 enhanced ovalbumin uptake into intestinal antigen presenting MHC II + CD11c + cells and their CD11b + CD103 + and CD11b + CD103 - subtype dendritic cells, which are the major antigen presenting subsets of the intestinal tract, more efficiently compared to without SF-10. Oral vaccination with influenza hemagglutinin vaccine (HAv)-SF-10 induced HAv-specific IgA and IgG in the serum, and HAv-specific secretory IgA and IgG in bronchoalveolar lavage fluid, nasal washes, gastric extracts and fecal material; their levels were significantly higher than those induced by subcutaneous HAv or intranasal HAv and HAv-SF-10 vaccinations. Enzyme-linked immunospot assay showed high numbers of HAv-specific IgA and IgG antibody secreting cells in the gastrointestinal and respiratory mucosal lymphoid tissues after oral vaccination with HAv-SF-10, but no or very low induction following oral vaccination with HAv alone. Oral vaccination with HAv-SF-10 provided protective immunity against severe influenza A virus infection, which was significantly higher than that induced by HAv combined with cholera toxin. Oral vaccination with HAv-SF-10 was associated with unique cytokine production patterns in the spleen after HAv stimulation; including marked induction of HAv-responsive Th17 cytokines (e.g., IL-17A and IL-22), high induction of Th1 cytokines (e.g., IL-2 and IFN-\u03b3) and moderate induction of Th2 cytokines (e.g., IL-4 and IL-5). These results indicate that oral vaccination with HAv-SF-10 induces more efficient systemic and local immunity than nasal or subcutaneous vaccination with characteristically high levels of secretory HAv-specific IgA in various mucosal organs and protective immunity. ",
    "author_highlights": [
        {
            "endOffset": 16462,
            "sentence": "Synthetic surfactant adjuvant SF-10 promoted antigen delivery to dendritic cells.",
            "startOffset": 16381
        },
        {
            "endOffset": 16543,
            "sentence": "HAv-SF-10(p.o.) induced systemic/local immunity and protected against influenza.",
            "startOffset": 16463
        },
        {
            "endOffset": 16626,
            "sentence": "Mucosal anti-HAv IgA induced by HAv-SF-10(p.o.) were higher than by cholera toxin.",
            "startOffset": 16544
        },
        {
            "endOffset": 16703,
            "sentence": "HAv-SF-10(p.o.) elicited Th17 cytokines markedly plus Th1 and Th2 cytokines.",
            "startOffset": 16627
        }
    ],
    "bib_entries": {
        "b0005": null,
        "b0010": {
            "authors": [
                {
                    "first": "C. E.",
                    "initial": "C.E.",
                    "last": "Watson"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Bell"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Toohey-Kurth"
                }
            ],
            "doi": "10.1177/0300985816681411",
            "firstpage": "527",
            "issn": "03009858",
            "lastpage": "530",
            "pmid": "28438112",
            "pub_year": 2017,
            "title": "H3N2 Canine Influenza Virus Infection in a Dog",
            "volume": "54"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Christopher T.",
                    "initial": "C.T.",
                    "last": "Lee"
                },
                {
                    "first": "Sally",
                    "initial": "S.",
                    "last": "Slavinski"
                },
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Schiff"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Merlino"
                },
                {
                    "first": "Demetre",
                    "initial": "D.",
                    "last": "Daskalakis"
                },
                {
                    "first": "Dakai",
                    "initial": "D.",
                    "last": "Liu"
                },
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "Rakeman"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Misener"
                },
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Thompson"
                },
                {
                    "first": "Yin Ling",
                    "initial": "Y.L.",
                    "last": "Leung"
                },
                {
                    "first": "Jay K.",
                    "initial": "J.K.",
                    "last": "Varma"
                },
                {
                    "first": "Alicia",
                    "initial": "A.",
                    "last": "Fry"
                },
                {
                    "first": "Fiona",
                    "initial": "F.",
                    "last": "Havers"
                },
                {
                    "first": "Todd",
                    "initial": "T.",
                    "last": "Davis"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Newbury"
                },
                {
                    "first": "Marcelle",
                    "initial": "M.",
                    "last": "Layton"
                },
                {
                    "first": "Bisrat",
                    "initial": "B.",
                    "last": "Abraham"
                },
                {
                    "first": "Joel",
                    "initial": "J.",
                    "last": "Ackelsberg"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Antwi"
                },
                {
                    "first": "Sharon",
                    "initial": "S.",
                    "last": "Balter"
                },
                {
                    "first": "Alexander",
                    "initial": "A.",
                    "last": "Davidson"
                },
                {
                    "first": "Paula Del",
                    "initial": "P.D.",
                    "last": "Rosso"
                },
                {
                    "first": "Katelynn",
                    "initial": "K.",
                    "last": "Devinney"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Dorsinville"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Fine"
                },
                {
                    "first": "Bruce",
                    "initial": "B.",
                    "last": "Gutelius"
                },
                {
                    "first": "Lucretia",
                    "initial": "L.",
                    "last": "Jones"
                },
                {
                    "first": "Ellen",
                    "initial": "E.",
                    "last": "Lee"
                },
                {
                    "first": "Kristen",
                    "initial": "K.",
                    "last": "Lee"
                },
                {
                    "first": "Natasha",
                    "initial": "N.",
                    "last": "McIntosh"
                },
                {
                    "first": "Nana",
                    "initial": "N.",
                    "last": "Mensah"
                },
                {
                    "first": "Sam",
                    "initial": "S.",
                    "last": "Miller"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Moskin"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Ng"
                },
                {
                    "first": "Stephanie",
                    "initial": "S.",
                    "last": "Ngai"
                },
                {
                    "first": "Beth",
                    "initial": "B.",
                    "last": "Nivin"
                },
                {
                    "first": "Carolyn",
                    "initial": "C.",
                    "last": "Olson"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Paladini"
                },
                {
                    "first": "Hilary",
                    "initial": "H.",
                    "last": "Parton"
                },
                {
                    "first": "Carolina",
                    "initial": "C.",
                    "last": "Pichardo"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Porter"
                },
                {
                    "first": "Ingrid",
                    "initial": "I.",
                    "last": "Ramlakhan"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Schroeder"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Starr"
                },
                {
                    "first": "Norma",
                    "initial": "N.",
                    "last": "Torres"
                },
                {
                    "first": "Don",
                    "initial": "D.",
                    "last": "Weiss"
                },
                {
                    "first": "Emily",
                    "initial": "E.",
                    "last": "Westheimer"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Hall"
                },
                {
                    "first": "Tina",
                    "initial": "T.",
                    "last": "Obijo"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Lindstrom"
                },
                {
                    "first": "Atanaska",
                    "initial": "A.",
                    "last": "Marinova-Petkova"
                },
                {
                    "first": "Kathy",
                    "initial": "K.",
                    "last": "Toohey-Kurth"
                },
                {
                    "first": "Mia",
                    "initial": "M.",
                    "last": "Torchetti"
                },
                {
                    "first": "Risa",
                    "initial": "R.",
                    "last": "Weinstoc"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1093/cid/cix668",
            "firstpage": "1927",
            "issn": "10584838",
            "lastpage": "1929",
            "pmid": "29020187",
            "pub_year": 2017,
            "title": "Outbreak of Influenza A(H7N2) among Cats in an Animal Shelter with Cat-to-Human Transmission - New York City, 2016",
            "volume": "65"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Gabriele",
                    "initial": "G.",
                    "last": "Neumann"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Noda"
                },
                {
                    "first": "Yoshihiro",
                    "initial": "Y.",
                    "last": "Kawaoka"
                }
            ],
            "doi": "10.1038/nature08157",
            "firstpage": "931",
            "issn": "00280836",
            "lastpage": "939",
            "pmid": "19525932",
            "pub_year": 2009,
            "title": "Emergence and pandemic potential of swine-origin H1N1 influenza virus",
            "volume": "459"
        },
        "b0025": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Chen"
                },
                {
                    "first": "G. J.D.",
                    "initial": "G.J.D.",
                    "last": "Smith"
                },
                {
                    "first": "S. Y.",
                    "initial": "S.Y.",
                    "last": "Zhang"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Qin"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "K. S.",
                    "initial": "K.S.",
                    "last": "Li"
                },
                {
                    "first": "R. G.",
                    "initial": "R.G.",
                    "last": "Webster"
                },
                {
                    "first": "J. S.M.",
                    "initial": "J.S.M.",
                    "last": "Peiris"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Guan"
                }
            ],
            "doi": "10.1038/nature03974",
            "firstpage": "191",
            "issn": "00280836",
            "lastpage": "192",
            "pmid": "16007072",
            "pub_year": 2005,
            "title": "Avian flu: H5N1 virus outbreak in migratory waterfowl",
            "volume": "436"
        },
        "b0030": {
            "authors": [
                {
                    "first": "John M.",
                    "initial": "J.M.",
                    "last": "Nicholls"
                },
                {
                    "first": "Renee W.Y.",
                    "initial": "R.W.Y.",
                    "last": "Chan"
                },
                {
                    "first": "Rupert J.",
                    "initial": "R.J.",
                    "last": "Russell"
                },
                {
                    "first": "Gillian M.",
                    "initial": "G.M.",
                    "last": "Air"
                },
                {
                    "first": "J. S.Malik",
                    "initial": "J.S.M.",
                    "last": "Peiris"
                }
            ],
            "doi": "10.1016/j.tim.2008.01.008",
            "firstpage": "149",
            "issn": "0966842X",
            "lastpage": "157",
            "pmid": "18375125",
            "pub_year": 2008,
            "title": "Evolving complexities of influenza virus and its receptors",
            "volume": "16"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Kyoko",
                    "initial": "K.",
                    "last": "Shinya"
                },
                {
                    "first": "Masahito",
                    "initial": "M.",
                    "last": "Ebina"
                },
                {
                    "first": "Shinya",
                    "initial": "S.",
                    "last": "Yamada"
                },
                {
                    "first": "Masao",
                    "initial": "M.",
                    "last": "Ono"
                },
                {
                    "first": "Noriyuki",
                    "initial": "N.",
                    "last": "Kasai"
                },
                {
                    "first": "Yoshihiro",
                    "initial": "Y.",
                    "last": "Kawaoka"
                }
            ],
            "doi": "10.1038/440435a",
            "firstpage": "435",
            "issn": "00280836",
            "lastpage": "436",
            "pmid": "16554799",
            "pub_year": 2006,
            "title": "Influenza virus receptors in the human airway",
            "volume": "440"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Kyoko",
                    "initial": "K.",
                    "last": "Shinya"
                },
                {
                    "first": "Akiko",
                    "initial": "A.",
                    "last": "Makino"
                },
                {
                    "first": "Hiroji",
                    "initial": "H.",
                    "last": "Tanaka"
                },
                {
                    "first": "Masato",
                    "initial": "M.",
                    "last": "Hatta"
                },
                {
                    "first": "Tokiko",
                    "initial": "T.",
                    "last": "Watanabe"
                },
                {
                    "first": "Mai Q.",
                    "initial": "M.Q.",
                    "last": "Le"
                },
                {
                    "first": "Hirotaka",
                    "initial": "H.",
                    "last": "Imai"
                },
                {
                    "first": "Yoshihiro",
                    "initial": "Y.",
                    "last": "Kawaoka"
                }
            ],
            "doi": "10.1128/JVI.00148-11",
            "firstpage": "4673",
            "issn": "0022538X",
            "lastpage": "4678",
            "pmid": "21411541",
            "pub_year": 2011,
            "title": "Systemic dissemination of H5N1 influenza a viruses in ferrets and hamsters after direct intragastric inoculation",
            "volume": "85"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                }
            ],
            "doi": "10.1038/nrd4529",
            "firstpage": "167",
            "issn": "14741776",
            "lastpage": "182",
            "pmid": "25722244",
            "pub_year": 2015,
            "title": "Advances in the development of influenza virus vaccines",
            "volume": "14"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Shin Ichi",
                    "initial": "S.I.",
                    "last": "Tamura"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Kurata"
                }
            ],
            "firstpage": "236",
            "issn": "13446304",
            "lastpage": "247",
            "pmid": "15623947",
            "pub_year": 2004,
            "title": "Defense mechanisms against influenza virus infection in the respiratory tract mucosa",
            "volume": "57"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Dai",
                    "initial": "D.",
                    "last": "Mizuno"
                },
                {
                    "first": "Mikiko",
                    "initial": "M.",
                    "last": "Ide-Kurihara"
                },
                {
                    "first": "Tomoko",
                    "initial": "T.",
                    "last": "Ichinomiya"
                },
                {
                    "first": "Itsuka",
                    "initial": "I.",
                    "last": "Kubo"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Kido"
                }
            ],
            "doi": "10.4049/jimmunol.176.2.1122",
            "firstpage": "1122",
            "issn": "00221767",
            "lastpage": "1130",
            "pmid": "16394001",
            "pub_year": 2006,
            "title": "Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen",
            "volume": "176"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Takashi",
                    "initial": "T.",
                    "last": "Kimoto"
                },
                {
                    "first": "Dai",
                    "initial": "D.",
                    "last": "Mizuno"
                },
                {
                    "first": "Tsunetomo",
                    "initial": "T.",
                    "last": "Takei"
                },
                {
                    "first": "Takuya",
                    "initial": "T.",
                    "last": "Kunimi"
                },
                {
                    "first": "Shinji",
                    "initial": "S.",
                    "last": "Ono"
                },
                {
                    "first": "Satoko",
                    "initial": "S.",
                    "last": "Sakai"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Kido"
                }
            ],
            "doi": "10.1111/irv.12124",
            "firstpage": "1218",
            "issn": "17502640",
            "lastpage": "1226",
            "pmid": "23710832",
            "pub_year": 2013,
            "title": "Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: Induction of potent local and systemic immunity with balanced Th1 and Th2 responses",
            "volume": "7"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Margot",
                    "initial": "M.",
                    "last": "Mutsch"
                },
                {
                    "first": "Weigong",
                    "initial": "W.",
                    "last": "Zhou"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Rhodes"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Bopp"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Chen"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Linder"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Spyr"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Steffen"
                }
            ],
            "doi": "10.1056/NEJMoa030595",
            "firstpage": "896",
            "issn": "00284793",
            "lastpage": "903",
            "pmid": "14985487",
            "pub_year": 2004,
            "title": "Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland",
            "volume": "350"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Maki",
                    "initial": "M.",
                    "last": "Nishino"
                },
                {
                    "first": "Dai",
                    "initial": "D.",
                    "last": "Mizuno"
                },
                {
                    "first": "Takashi",
                    "initial": "T.",
                    "last": "Kimoto"
                },
                {
                    "first": "Wakako",
                    "initial": "W.",
                    "last": "Shinahara"
                },
                {
                    "first": "Akiho",
                    "initial": "A.",
                    "last": "Fukuta"
                },
                {
                    "first": "Tsunetomo",
                    "initial": "T.",
                    "last": "Takei"
                },
                {
                    "first": "Kaori",
                    "initial": "K.",
                    "last": "Sumida"
                },
                {
                    "first": "Seiichiro",
                    "initial": "S.",
                    "last": "Kitamura"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Shiota"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Kido"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.07.024",
            "firstpage": "5620",
            "issn": "0264410X",
            "lastpage": "5627",
            "pmid": "19647064",
            "pub_year": 2009,
            "title": "Influenza vaccine with Surfacten, a modified pulmonary surfactant, induces systemic and mucosal immune responses without side effects in minipigs",
            "volume": "27"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Dai",
                    "initial": "D.",
                    "last": "Mizuno"
                },
                {
                    "first": "Takashi",
                    "initial": "T.",
                    "last": "Kimoto"
                },
                {
                    "first": "Tsunetomo",
                    "initial": "T.",
                    "last": "Takei"
                },
                {
                    "first": "Akiho",
                    "initial": "A.",
                    "last": "Fukuta"
                },
                {
                    "first": "Wakako",
                    "initial": "W.",
                    "last": "Shinahara"
                },
                {
                    "first": "Etsuhisa",
                    "initial": "E.",
                    "last": "Takahashi"
                },
                {
                    "first": "Mihiro",
                    "initial": "M.",
                    "last": "Yano"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Kido"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.05.090",
            "firstpage": "5368",
            "issn": "0264410X",
            "lastpage": "5378",
            "pmid": "21669246",
            "pub_year": 2011,
            "title": "Surfactant protein c is an essential constituent for mucosal adjuvanticity of surfacten, acting as an antigen delivery vehicle and inducing both local and systemic immunity",
            "volume": "29"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Dai",
                    "initial": "D.",
                    "last": "Mizuno"
                },
                {
                    "first": "Takashi",
                    "initial": "T.",
                    "last": "Kimoto"
                },
                {
                    "first": "Satoko",
                    "initial": "S.",
                    "last": "Sakai"
                },
                {
                    "first": "Etsuhisa",
                    "initial": "E.",
                    "last": "Takahashi"
                },
                {
                    "first": "Hyejin",
                    "initial": "H.",
                    "last": "Kim"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Kido"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.02.061",
            "firstpage": "1881",
            "issn": "0264410X",
            "lastpage": "1888",
            "pmid": "26954466",
            "pub_year": 2016,
            "title": "Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys",
            "volume": "34"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Hyejin",
                    "initial": "H.",
                    "last": "Kim"
                },
                {
                    "first": "Takashi",
                    "initial": "T.",
                    "last": "Kimoto"
                },
                {
                    "first": "Satoko",
                    "initial": "S.",
                    "last": "Sakai"
                },
                {
                    "first": "Etsuhisa",
                    "initial": "E.",
                    "last": "Takahashi"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Kido"
                }
            ],
            "doi": "10.1371/journal.pone.0191133",
            "issn": "19326203",
            "pmid": "29370185",
            "pub_year": 2018,
            "title": "Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactantmimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice",
            "volume": "13"
        },
        "b0090": {
            "authors": [
                {
                    "first": "J. R.",
                    "initial": "J.R.",
                    "last": "Wright"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Clements"
                }
            ],
            "doi": "10.1164/ajrccm/136.2.426",
            "firstpage": "426",
            "issn": "00030805",
            "lastpage": "444",
            "pmid": "3304047",
            "pub_year": 1987,
            "title": "Metabolism and turnover of lung surfactant",
            "volume": "136"
        },
        "b0095": {
            "authors": [
                {
                    "first": "G. E.R.",
                    "initial": "G.E.R.",
                    "last": "Hook"
                },
                {
                    "first": "L. B.",
                    "initial": "L.B.",
                    "last": "Gilmore"
                },
                {
                    "first": "E. G.",
                    "initial": "E.G.",
                    "last": "Tombropoulos"
                },
                {
                    "first": "S. E.",
                    "initial": "S.E.",
                    "last": "Fabro"
                }
            ],
            "firstpage": "541",
            "issn": "00030805",
            "lastpage": "550",
            "pmid": "629487",
            "pub_year": 1978,
            "title": "Fetal lung lamellar bodies in human amniotic fluid",
            "volume": "117"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Koji",
                    "initial": "K.",
                    "last": "Nishijima"
                },
                {
                    "first": "Ken Ichi",
                    "initial": "K.I.",
                    "last": "Shukunami"
                },
                {
                    "first": "Hirokazu",
                    "initial": "H.",
                    "last": "Tsukahara"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Orisaka"
                },
                {
                    "first": "Jun'ichiro",
                    "initial": "J.",
                    "last": "Miura"
                },
                {
                    "first": "Fumikazu",
                    "initial": "F.",
                    "last": "Kotsuji"
                }
            ],
            "doi": "10.1203/01.pdr.0000228329.90502.3a",
            "firstpage": "196",
            "issn": "00313998",
            "lastpage": "199",
            "pmid": "16864703",
            "pub_year": 2006,
            "title": "Micelles of pulmonary surfactant in human amniotic fluid at term",
            "volume": "60"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Koji",
                    "initial": "K.",
                    "last": "Nishijima"
                },
                {
                    "first": "Ken Ichi",
                    "initial": "K.I.",
                    "last": "Shukunami"
                },
                {
                    "first": "Hideo",
                    "initial": "H.",
                    "last": "Yoshinari"
                },
                {
                    "first": "Jin",
                    "initial": "J.",
                    "last": "Takahashi"
                },
                {
                    "first": "Hideyuki",
                    "initial": "H.",
                    "last": "Maeda"
                },
                {
                    "first": "Hitoshi",
                    "initial": "H.",
                    "last": "Takagi"
                },
                {
                    "first": "Fumikazu",
                    "initial": "F.",
                    "last": "Kotsuji"
                }
            ],
            "doi": "10.1152/ajplung.00081.2011",
            "firstpage": "L208",
            "issn": "10400605",
            "lastpage": "L214",
            "pmid": "22637154",
            "pub_year": 2012,
            "title": "Interactions among pulmonary surfactant, vernix caseosa, and intestinal enterocytes: Intra-amniotic administration of fluorescently liposomes to pregnant rabbits",
            "volume": "303"
        },
        "b0110": {
            "authors": [
                {
                    "first": "J. D.",
                    "initial": "J.D.",
                    "last": "Barackman"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Ott"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Pine"
                },
                {
                    "first": "D. T.",
                    "initial": "D.T.",
                    "last": "O'Hagan"
                }
            ],
            "doi": "10.1128/CDLI.8.3.652-657.2001",
            "firstpage": "652",
            "issn": "1071412X",
            "lastpage": "657",
            "pmid": "11329476",
            "pub_year": 2001,
            "title": "Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization",
            "volume": "8"
        },
        "b0115": {
            "authors": [
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Katz"
                },
                {
                    "first": "X.",
                    "initial": "X.",
                    "last": "Lu"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "Young"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Galphin"
                }
            ],
            "doi": "10.1093/infdis/175.2.352",
            "firstpage": "352",
            "issn": "00221899",
            "lastpage": "363",
            "pmid": "9203656",
            "pub_year": 1997,
            "title": "Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine",
            "volume": "175"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Jamie F.S.",
                    "initial": "J.F.S.",
                    "last": "Mann"
                },
                {
                    "first": "Eisin",
                    "initial": "E.",
                    "last": "Shakir"
                },
                {
                    "first": "Katharine C.",
                    "initial": "K.C.",
                    "last": "Carter"
                },
                {
                    "first": "Alexander B.",
                    "initial": "A.B.",
                    "last": "Mullen"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Alexander"
                },
                {
                    "first": "Valerie A.",
                    "initial": "V.A.",
                    "last": "Ferro"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.03.040",
            "firstpage": "3643",
            "issn": "0264410X",
            "lastpage": "3649",
            "pmid": "19464545",
            "pub_year": 2009,
            "title": "Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection",
            "volume": "27"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Ciaran D.",
                    "initial": "C.D.",
                    "last": "Scallan"
                },
                {
                    "first": "Debora W.",
                    "initial": "D.W.",
                    "last": "Tingley"
                },
                {
                    "first": "Jonathan D.",
                    "initial": "J.D.",
                    "last": "Lindbloom"
                },
                {
                    "first": "James S.",
                    "initial": "J.S.",
                    "last": "Toomey"
                },
                {
                    "first": "Sean N.",
                    "initial": "S.N.",
                    "last": "Tucker"
                }
            ],
            "doi": "10.1128/CVI.00552-12",
            "firstpage": "85",
            "issn": "15566811",
            "lastpage": "94",
            "pmid": "23155123",
            "pub_year": 2013,
            "title": "An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models",
            "volume": "20"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Gurwith"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Lock"
                },
                {
                    "first": "Eve M.",
                    "initial": "E.M.",
                    "last": "Taylor"
                },
                {
                    "first": "Glenn",
                    "initial": "G.",
                    "last": "Ishioka"
                },
                {
                    "first": "Jeff",
                    "initial": "J.",
                    "last": "Alexander"
                },
                {
                    "first": "Tim",
                    "initial": "T.",
                    "last": "Mayall"
                },
                {
                    "first": "John E.",
                    "initial": "J.E.",
                    "last": "Ervin"
                },
                {
                    "first": "Richard N.",
                    "initial": "R.N.",
                    "last": "Greenberg"
                },
                {
                    "first": "Cynthia",
                    "initial": "C.",
                    "last": "Strout"
                },
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Treanor"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Webby"
                },
                {
                    "first": "Peter F.",
                    "initial": "P.F.",
                    "last": "Wright"
                }
            ],
            "doi": "10.1016/S1473-3099(12)70345-6",
            "firstpage": "238",
            "issn": "14733099",
            "lastpage": "250",
            "pmid": "23369412",
            "pub_year": 2013,
            "title": "Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: A Randomised, double-blind, placebo-controlled, phase 1 study",
            "volume": "13"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Liu"
                },
                {
                    "first": "Jianqi",
                    "initial": "J.",
                    "last": "Wu"
                },
                {
                    "first": "Bing",
                    "initial": "B.",
                    "last": "Wang"
                },
                {
                    "first": "Sheng",
                    "initial": "S.",
                    "last": "Zeng"
                },
                {
                    "first": "Feifei",
                    "initial": "F.",
                    "last": "Qi"
                },
                {
                    "first": "Changlong",
                    "initial": "C.",
                    "last": "Lu"
                },
                {
                    "first": "Yoshinobu",
                    "initial": "Y.",
                    "last": "Kimura"
                },
                {
                    "first": "Beixing",
                    "initial": "B.",
                    "last": "Liu"
                }
            ],
            "doi": "10.1002/jmv.23768",
            "firstpage": "886",
            "issn": "01466615",
            "lastpage": "894",
            "pmid": "24122866",
            "pub_year": 2014,
            "title": "Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection",
            "volume": "86"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Md M.",
                    "initial": "M.M.",
                    "last": "Rahman"
                },
                {
                    "first": "Erdenebileg",
                    "initial": "E.",
                    "last": "Uyangaa"
                },
                {
                    "first": "Young W.",
                    "initial": "Y.W.",
                    "last": "Han"
                },
                {
                    "first": "Seong B.",
                    "initial": "S.B.",
                    "last": "Kim"
                },
                {
                    "first": "Jin H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Jin Y.",
                    "initial": "J.Y.",
                    "last": "Choi"
                },
                {
                    "first": "Seong K.",
                    "initial": "S.K.",
                    "last": "Eo"
                }
            ],
            "doi": "10.1186/1746-6148-8-105",
            "issn": "17466148",
            "pmid": "22776696",
            "pub_year": 2012,
            "title": "Enhancement of Th1-biased protective immunity against avian influenza H9N2 virus via oral co-administration of attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-\u03b1 and interleukin-18 along with an inactivated vaccine",
            "volume": "8"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Zenglin",
                    "initial": "Z.",
                    "last": "Pei"
                },
                {
                    "first": "Xiaohong",
                    "initial": "X.",
                    "last": "Jiang"
                },
                {
                    "first": "Zhu",
                    "initial": "Z.",
                    "last": "Yang"
                },
                {
                    "first": "Xiaoguang",
                    "initial": "X.",
                    "last": "Ren"
                },
                {
                    "first": "Hao",
                    "initial": "H.",
                    "last": "Gong"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Reeves"
                },
                {
                    "first": "Jingxue",
                    "initial": "J.",
                    "last": "Sheng"
                },
                {
                    "first": "Yu",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Zishu",
                    "initial": "Z.",
                    "last": "Pan"
                },
                {
                    "first": "Fenyong",
                    "initial": "F.",
                    "last": "Liu"
                },
                {
                    "first": "Jianguo",
                    "initial": "J.",
                    "last": "Wu"
                },
                {
                    "first": "Sangwei",
                    "initial": "S.",
                    "last": "Lu"
                }
            ],
            "doi": "10.1371/journal.pone.0129276",
            "issn": "19326203",
            "pmid": "26083421",
            "pub_year": 2015,
            "title": "Oral delivery of a novel attenuated salmonella vaccine expressing influenza a virus proteins protects mice against H5N1 and H1N1 viral infection",
            "volume": "10"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Jiri",
                    "initial": "J.",
                    "last": "Mestecky"
                }
            ],
            "doi": "10.1007/BF00915547",
            "firstpage": "265",
            "issn": "02719142",
            "lastpage": "276",
            "pmid": "3301884",
            "pub_year": 1987,
            "title": "The common mucosal immune system and current strategies for induction of immune responses in external secretions",
            "volume": "7"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Akihito",
                    "initial": "A.",
                    "last": "Harusato"
                },
                {
                    "first": "Duke",
                    "initial": "D.",
                    "last": "Geem"
                },
                {
                    "first": "Timothy L.",
                    "initial": "T.L.",
                    "last": "Denning"
                }
            ],
            "doi": "10.1007/978-1-4939-3603-8_16",
            "firstpage": "171",
            "issn": "10643745",
            "lastpage": "180",
            "pmid": "27246032",
            "pub_year": 2016,
            "title": "Macrophage isolation from the mouse small and large intestine",
            "volume": "1422"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Etsuhisa",
                    "initial": "E.",
                    "last": "Takahashi"
                },
                {
                    "first": "Kosuke",
                    "initial": "K.",
                    "last": "Kataoka"
                },
                {
                    "first": "Kazuyuki",
                    "initial": "K.",
                    "last": "Fujii"
                },
                {
                    "first": "Junji",
                    "initial": "J.",
                    "last": "Chida"
                },
                {
                    "first": "Dai",
                    "initial": "D.",
                    "last": "Mizuno"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Fukui"
                },
                {
                    "first": "Hiro O.",
                    "initial": "H.O.",
                    "last": "Ito"
                },
                {
                    "first": "Kohtaro",
                    "initial": "K.",
                    "last": "Fujihashi"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Kido"
                }
            ],
            "doi": "10.1016/j.micinf.2010.04.013",
            "firstpage": "778",
            "issn": "12864579",
            "lastpage": "783",
            "pmid": "20452454",
            "pub_year": 2010,
            "title": "Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus",
            "volume": "12"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Kyle L.",
                    "initial": "K.L.",
                    "last": "Flannigan"
                },
                {
                    "first": "Duke",
                    "initial": "D.",
                    "last": "Geem"
                },
                {
                    "first": "Akihito",
                    "initial": "A.",
                    "last": "Harusato"
                },
                {
                    "first": "Timothy L.",
                    "initial": "T.L.",
                    "last": "Denning"
                }
            ],
            "doi": "10.1016/j.ajpath.2015.02.024",
            "firstpage": "1809",
            "issn": "00029440",
            "lastpage": "1819",
            "pmid": "25976247",
            "pub_year": 2015,
            "title": "Intestinal Antigen-Presenting Cells: Key Regulators of Immune Homeostasis and Inflammation",
            "volume": "185"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Okyanus",
                    "initial": "O.",
                    "last": "Gurel"
                },
                {
                    "first": "Machiko",
                    "initial": "M.",
                    "last": "Ikegami"
                },
                {
                    "first": "Zissis C.",
                    "initial": "Z.C.",
                    "last": "Chroneos"
                },
                {
                    "first": "Alan H.",
                    "initial": "A.H.",
                    "last": "Jobe"
                }
            ],
            "doi": "10.1152/ajplung.2001.280.6.l1266",
            "firstpage": "L1266",
            "issn": "10400605",
            "lastpage": "L1272",
            "pmid": "11350807",
            "pub_year": 2001,
            "title": "Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs",
            "volume": "280"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Darren Thomas",
                    "initial": "D.T.",
                    "last": "Ruane"
                },
                {
                    "first": "Ed C.",
                    "initial": "E.C.",
                    "last": "Lavelle"
                }
            ],
            "doi": "10.3389/fimmu.2011.00025",
            "issn": "16643224",
            "pub_year": 2011,
            "title": "The role of CD103+ dendritic cells in the intestinal mucosal immune system",
            "volume": "2"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Janine L.",
                    "initial": "J.L.",
                    "last": "Coombes"
                },
                {
                    "first": "Karima R.R.",
                    "initial": "K.R.R.",
                    "last": "Siddiqui"
                },
                {
                    "first": "Carolina V.",
                    "initial": "C.V.",
                    "last": "Arancibia-C\u00e1rcamo"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Hall"
                },
                {
                    "first": "Cheng Ming",
                    "initial": "C.M.",
                    "last": "Sun"
                },
                {
                    "first": "Yasmine",
                    "initial": "Y.",
                    "last": "Belkaid"
                },
                {
                    "first": "Fiona",
                    "initial": "F.",
                    "last": "Powrie"
                }
            ],
            "doi": "10.1084/jem.20070590",
            "firstpage": "1757",
            "issn": "00221007",
            "lastpage": "1764",
            "pmid": "17620361",
            "pub_year": 2007,
            "title": "A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-\u03b2 -and retinoic acid-dependent mechanism",
            "volume": "204"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Yingzi",
                    "initial": "Y.",
                    "last": "Cong"
                },
                {
                    "first": "Ting",
                    "initial": "T.",
                    "last": "Feng"
                },
                {
                    "first": "Kohtaro",
                    "initial": "K.",
                    "last": "Fujihashi"
                },
                {
                    "first": "Trenton R.",
                    "initial": "T.R.",
                    "last": "Schoeb"
                },
                {
                    "first": "Charles O.",
                    "initial": "C.O.",
                    "last": "Elson"
                }
            ],
            "doi": "10.1073/pnas.0812681106",
            "firstpage": "19256",
            "issn": "00278424",
            "lastpage": "19261",
            "pmid": "19889972",
            "pub_year": 2009,
            "title": "A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota",
            "volume": "106"
        },
        "b0190": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Flores-Langarica"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "M\u00fcller Luda"
                },
                {
                    "first": "E. K.",
                    "initial": "E.K.",
                    "last": "Persson"
                },
                {
                    "first": "C. N.",
                    "initial": "C.N.",
                    "last": "Cook"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Bobat"
                },
                {
                    "first": "J. L.",
                    "initial": "J.L.",
                    "last": "Marshall"
                },
                {
                    "first": "M. W.",
                    "initial": "M.W.",
                    "last": "Dahlgren"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "H\u00e4gerbrand"
                },
                {
                    "first": "K. M.",
                    "initial": "K.M.",
                    "last": "Toellner"
                },
                {
                    "first": "M. D.",
                    "initial": "M.D.",
                    "last": "Goodall"
                },
                {
                    "first": "D. R.",
                    "initial": "D.R.",
                    "last": "Withers"
                },
                {
                    "first": "I. R.",
                    "initial": "I.R.",
                    "last": "Henderson"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Johansson Lindbom"
                },
                {
                    "first": "A. F.",
                    "initial": "A.F.",
                    "last": "Cunningham"
                },
                {
                    "first": "W. W.",
                    "initial": "W.W.",
                    "last": "Agace"
                }
            ],
            "doi": "10.1038/mi.2017.105",
            "firstpage": "681",
            "issn": "19330219",
            "lastpage": "692",
            "pmid": "29346347",
            "pub_year": 2018,
            "title": "CD103 + CD11b + mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin",
            "volume": "11"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Aayam",
                    "initial": "A.",
                    "last": "Lamichhane"
                },
                {
                    "first": "Tatsuhiko",
                    "initial": "T.",
                    "last": "Azegami"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Kiyono"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.08.089",
            "firstpage": "6711",
            "issn": "0264410X",
            "lastpage": "6723",
            "pmid": "25454857",
            "pub_year": 2014,
            "title": "The mucosal immune system for vaccine development",
            "volume": "32"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Akhilesh Kumar",
                    "initial": "A.K.",
                    "last": "Shakya"
                },
                {
                    "first": "Mohammed Y.E.",
                    "initial": "M.Y.E.",
                    "last": "Chowdhury"
                },
                {
                    "first": "Wenqian",
                    "initial": "W.",
                    "last": "Tao"
                },
                {
                    "first": "Harvinder Singh",
                    "initial": "H.S.",
                    "last": "Gill"
                }
            ],
            "doi": "10.1016/j.jconrel.2016.02.014",
            "firstpage": "394",
            "issn": "01683659",
            "lastpage": "413",
            "pmid": "26860287",
            "pub_year": 2016,
            "title": "Mucosal vaccine delivery: Current state and a pediatric perspective",
            "volume": "240"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Laurie E.",
                    "initial": "L.E.",
                    "last": "Harrington"
                },
                {
                    "first": "Robin D.",
                    "initial": "R.D.",
                    "last": "Hatton"
                },
                {
                    "first": "Paul R.",
                    "initial": "P.R.",
                    "last": "Mangan"
                },
                {
                    "first": "Henrietta",
                    "initial": "H.",
                    "last": "Turner"
                },
                {
                    "first": "Theresa L.",
                    "initial": "T.L.",
                    "last": "Murphy"
                },
                {
                    "first": "Kenneth M.",
                    "initial": "K.M.",
                    "last": "Murphy"
                },
                {
                    "first": "Casey T.",
                    "initial": "C.T.",
                    "last": "Weaver"
                }
            ],
            "doi": "10.1038/ni1254",
            "firstpage": "1123",
            "issn": "15292908",
            "lastpage": "1132",
            "pmid": "16200070",
            "pub_year": 2005,
            "title": "Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages",
            "volume": "6"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Keiji",
                    "initial": "K.",
                    "last": "Hirota"
                },
                {
                    "first": "Jan Eric",
                    "initial": "J.E.",
                    "last": "Turner"
                },
                {
                    "first": "Matteo",
                    "initial": "M.",
                    "last": "Villa"
                },
                {
                    "first": "Jo\u00e3o H.",
                    "initial": "J.H.",
                    "last": "Duarte"
                },
                {
                    "first": "Jocelyne",
                    "initial": "J.",
                    "last": "Demengeot"
                },
                {
                    "first": "Oliver M.",
                    "initial": "O.M.",
                    "last": "Steinmetz"
                },
                {
                    "first": "Brigitta",
                    "initial": "B.",
                    "last": "Stockinger"
                }
            ],
            "doi": "10.1038/ni.2552",
            "firstpage": "372",
            "issn": "15292908",
            "lastpage": "379",
            "pmid": "23475182",
            "pub_year": 2013,
            "title": "Plasticity of TH 17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses",
            "volume": "14"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Zhang"
                },
                {
                    "first": "Hongyong",
                    "initial": "H.",
                    "last": "Li"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Hai"
                },
                {
                    "first": "Wei",
                    "initial": "W.",
                    "last": "Yin"
                },
                {
                    "first": "Wenjian",
                    "initial": "W.",
                    "last": "Li"
                },
                {
                    "first": "Boyang",
                    "initial": "B.",
                    "last": "Zheng"
                },
                {
                    "first": "Xiaomin",
                    "initial": "X.",
                    "last": "Du"
                },
                {
                    "first": "Na",
                    "initial": "N.",
                    "last": "Li"
                },
                {
                    "first": "Zhengzheng",
                    "initial": "Z.",
                    "last": "Zhang"
                },
                {
                    "first": "Yuqing",
                    "initial": "Y.",
                    "last": "Deng"
                },
                {
                    "first": "Ruihong",
                    "initial": "R.",
                    "last": "Zeng"
                },
                {
                    "first": "Lin",
                    "initial": "L.",
                    "last": "Wei"
                }
            ],
            "doi": "10.1128/JVI.02111-16",
            "issn": "0022538X",
            "pmid": "28275186",
            "pub_year": 2017,
            "title": "CpG in combination with an inhibitor of notch signaling suppresses formalin-inactivated respiratory syncytial virus-enhanced airway hyperresponsiveness and inflammation by inhibiting Th17 memory responses and promoting tissue-resident memory cells in lungs",
            "volume": "91"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Asher",
                    "initial": "A.",
                    "last": "Maroof"
                },
                {
                    "first": "Yvonne M.",
                    "initial": "Y.M.",
                    "last": "Yorgensen"
                },
                {
                    "first": "Yufeng",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Jay T.",
                    "initial": "J.T.",
                    "last": "Evans"
                }
            ],
            "doi": "10.1371/journal.ppat.1003875",
            "issn": "15537366",
            "pmid": "24465206",
            "pub_year": 2014,
            "title": "Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection",
            "volume": "10"
        },
        "b0225": null,
        "b0230": {
            "authors": [
                {
                    "first": "Hongming",
                    "initial": "H.",
                    "last": "Chen"
                },
                {
                    "first": "Vladimir",
                    "initial": "V.",
                    "last": "Torchilin"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Langer"
                }
            ],
            "doi": "10.1016/0168-3659(96)01459-9",
            "firstpage": "263",
            "issn": "01683659",
            "lastpage": "272",
            "pub_year": 1996,
            "title": "Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability",
            "volume": "42"
        }
    },
    "body_text": [
        {
            "endOffset": 33391,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 33390,
                    "startOffset": 33386
                }
            },
            "secId": "s0050",
            "sentence": "At days 4 and 7 after infection, the virus titers in BALF were measured by the plaque assay using Madin-Darby canine kidney cells and anti-IAV nucleoprotein monoclonal antibody, as described previously [32].",
            "startOffset": 33184,
            "title": "Protection against virus challenge in mice after oral vaccination"
        },
        {
            "endOffset": 42154,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Finally, we analyzed the protective immunity induced by two-time vaccination with HAv-SF-10(p.o.), by comparing HI titers in serum with those of HAv(p.o.) and HAv-CT(p.o.) (Fig. 5A).",
            "startOffset": 41972,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 22312,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 22254,
                    "startOffset": 22247
                },
                "b0080": {
                    "endOffset": 22254,
                    "startOffset": 22247
                },
                "b0085": {
                    "endOffset": 22311,
                    "startOffset": 22307
                }
            },
            "secId": "s0005",
            "sentence": "Antigen combined with SF-10 (antigen-SF-10) enhances absorption of antigens into nasal APCs and induces systemic and respiratory humoral immunity with induction of balanced antigen specific Th1/Th2 cells in mice and cynomolgus monkeys [12,16] and systemic cell-mediated immunity as well in mice [17].",
            "startOffset": 22012,
            "title": "Introduction"
        },
        {
            "endOffset": 28453,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Fecal extract was prepared by extraction of 100 mg feces from the cecum with 500 \u03bcL phosphate-buffered saline (PBS) containing protease inhibitors, e.g., 0.32 mg/mL benzamide (Sigma-Aldrich) and 2 \u03bcg/mL phenylmethylsulfonyl fluoride (Nacalai tesque).",
            "startOffset": 28203,
            "title": "Immunization and sampling of serum and mucosal fluid"
        },
        {
            "endOffset": 23189,
            "parents": [],
            "secId": "s0005",
            "sentence": "These findings suggest that pulmonary surfactant has a physiological function in the gastrointestinal tract apart from its function in the respiratory tract through efficient absorption by the intestinal mucosal epithelium.",
            "startOffset": 22966,
            "title": "Introduction"
        },
        {
            "endOffset": 26701,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0060": {
                    "endOffset": 26631,
                    "startOffset": 26627
                }
            },
            "secId": "s0020",
            "sentence": "Before administration, lyophilized antigen-SSF was dissolved with 1% CVP by mild mixing and then equal volume of saline [12] or 50 mM sodium bicarbonate buffer, pH 9.7, (carbo-buffer) was added.",
            "startOffset": 26507,
            "title": "Preparation of antigen-SF-10"
        },
        {
            "endOffset": 22582,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 22581,
                    "startOffset": 22577
                }
            },
            "secId": "s0005",
            "sentence": "The pulmonary surfactant is a biologically active natural substance secreted by alveolar type II epithelial cells, rapidly metabolized in the lungs, coats the alveolar surface, and lowers the surface tension of the air-liquid interface to prevent alveolar collapse [18].",
            "startOffset": 22312,
            "title": "Introduction"
        },
        {
            "endOffset": 38306,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The numbers of induced HAv-specific IgA and IgG spots of ASCs in the lung of mice immunized with HAv-SF-10(p.o.) were the highest among those of ASCs in the lymph nodes throughout the body analyzed.",
            "startOffset": 38108,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 46673,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 46672,
                    "startOffset": 46665
                },
                "b0200": {
                    "endOffset": 46672,
                    "startOffset": 46665
                }
            },
            "secId": "s0090",
            "sentence": "It has been reported that oral vaccination induces immune tolerance in general and, if anything, it is difficult to induce protective immunity efficiently by oral vaccination against infectious pathogens compared with other administration routes of vaccines, such as subcutaneous, intramuscular and intranasal administrations [39,40].",
            "startOffset": 46339,
            "title": "Discussion"
        },
        {
            "endOffset": 28080,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 28079,
                    "startOffset": 28075
                }
            },
            "secId": "s0025",
            "sentence": "After 2 weeks from the last inoculation, serum, nasal washes, and bronchoalveolar lavage fluids (BALF) were prepared as described previously [11].",
            "startOffset": 27934,
            "title": "Immunization and sampling of serum and mucosal fluid"
        },
        {
            "endOffset": 32453,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Serum was treated overnight with RDE (II) \u201cSEIKEN\u201d (Denka Seiken Co., Tokyo, Japan) at 37 \u00b0C.",
            "startOffset": 32360,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 47089,
            "parents": [],
            "secId": "s0090",
            "sentence": "Efficient induction of protective immunity by HAv-SF-10(p.o.) vaccination in Fig. 5 may be derived from effective vaccine delivery across intestinal mucosal surface barriers and antigen presentation in the gastrointestinal mucosal APCs, because pulmonary surfactant, the base compound of SF-10, is absorbed by the intestinal mucosal epithelium and respiratory epithelium and metabolized rapidly and physiologically.",
            "startOffset": 46674,
            "title": "Discussion"
        },
        {
            "endOffset": 27387,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "After starvation for 4 h, one group of mice were orally administered 1 \u03bcg HAv with or without 10 \u03bcg phospholipid-containing SF-10 [HAv-SF-10(p.o.)], lipopolysaccharide (LPS) (Nacalai tesque, Kyoto, Japan), Pam3CSK4 (InvivoGen, San Diego, CA), poly(I:C) (Alexis Biochemicals, Lausanne, Switzerland), CpG (InvivoGen), cholera toxin B subunit (CT-B) (Sigma-Aldrich, St. Louis, MO), or cholera toxin (CT) (Millipore, Billerica, MA) in 200 \u03bcL of 25 mM carbo-buffer by using a stainless steel mouse feeding needle (Fuchigami Co., Ltd., Kyoto, Japan, No. 4202, L \u00d7 diam.",
            "startOffset": 26824,
            "title": "Immunization and sampling of serum and mucosal fluid"
        },
        {
            "endOffset": 34089,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Statistical significance of the differences between experimental groups was calculated by ANOVA with a Bonferroni posttest, an unpaired Student\u2019s t-test (if variances were equal (F-test, P \u2265 0.05)) or Welch's t-test (if variances were unequal (F-test, P < 0.05)) using KaleidaGraph 4.5 software (Synergy Software, Reading, PA).",
            "startOffset": 33762,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 52551,
            "parents": [],
            "secId": "s0090",
            "sentence": "While the above results highlight the superiority of HAv-SF-10(p.o.) with regard to the induced systemic and local immunity, compared with the other preparations used in our study, they also indicate that anti-HAv S-IgA levels in the lungs induced by HAv-SF-10(p.o.) play pivotal roles in protection against IAV infection.",
            "startOffset": 52229,
            "title": "Discussion"
        },
        {
            "endOffset": 46338,
            "parents": [],
            "secId": "s0090",
            "sentence": "Since HAv-SF-10(p.o.) vaccination induced HAv specific systemic IgA and mucosal S-IgA very efficiently, SF-10 may stimulate the function of Th17 and regulatory T cells in the gastrointestinal tract.",
            "startOffset": 46140,
            "title": "Discussion"
        },
        {
            "endOffset": 20792,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 20791,
                    "startOffset": 20784
                },
                "b0075": {
                    "endOffset": 20791,
                    "startOffset": 20784
                }
            },
            "secId": "s0005",
            "sentence": "Pulmonary surfactant shows potent adjuvanticities as a delivery vehicle by promoting antigens uptake into mucosal antigen presenting cells (APCs), such as dendritic cells (DCs), but itself does not stimulate APCs without antigen [11,15].",
            "startOffset": 20555,
            "title": "Introduction"
        },
        {
            "endOffset": 23867,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 23709,
                    "startOffset": 23702
                },
                "b0115": {
                    "endOffset": 23709,
                    "startOffset": 23702
                },
                "b0120": {
                    "endOffset": 23739,
                    "startOffset": 23735
                },
                "b0125": {
                    "endOffset": 23799,
                    "startOffset": 23792
                },
                "b0130": {
                    "endOffset": 23799,
                    "startOffset": 23792
                },
                "b0135": {
                    "endOffset": 23820,
                    "startOffset": 23816
                },
                "b0140": {
                    "endOffset": 23851,
                    "startOffset": 23844
                },
                "b0145": {
                    "endOffset": 23851,
                    "startOffset": 23844
                }
            },
            "secId": "s0005",
            "sentence": "Although oral vaccination could result in gastrointestinal antigen digestion and acid inactivation of the antigen, compared with nasal vaccination, various oral influenza vaccines, combined with adjuvants, such as heat-labile enterotoxin-based adjuvants [22,23], liposome-based adjuvant [24], and influenza DNA vaccines using adenovirus vector [25,26], plasmid vector [27], and Salmonella vector [28,29] have been used.",
            "startOffset": 23448,
            "title": "Introduction"
        },
        {
            "endOffset": 40857,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "These data suggest that two-time vaccination with HAv-SF-10(p.o.) can provide protective immunity.",
            "startOffset": 40759,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 25666,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All mice used in this study were treated according to the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85\u201323, 1996).",
            "startOffset": 25525,
            "title": "Vaccine, virus and animals"
        },
        {
            "endOffset": 50016,
            "parents": [],
            "refoffsets": {
                "b0215": {
                    "endOffset": 49960,
                    "startOffset": 49956
                },
                "b0220": {
                    "endOffset": 49995,
                    "startOffset": 49991
                }
            },
            "secId": "s0090",
            "sentence": "The finding implies that the induced Th17-mediated immunity is one of the mechanisms of efficient induction of mucosal S-IgA by HAv-SF-10(p.o.), although the negative issues of Th17-mediated immune responses, such as hyperresponsiveness and inflammatory stimulation in the pathogenesis of the respiratory syncytial virus infection [43] and influenza virus infection [44], have been reported.",
            "startOffset": 49625,
            "title": "Discussion"
        },
        {
            "endOffset": 41218,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Two weeks after the last immunization, the levels of HAv-specific IgG in serum and S-IgA in BALF were measured by ELISA (Fig. 4C).",
            "startOffset": 41088,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 52942,
            "parents": [],
            "secId": "s0090",
            "sentence": "In the present study, we clarified the protective immunity induced by HAv-SF-10(p.o.) vaccination, but not yet the immune tolerance induction.",
            "startOffset": 52800,
            "title": "Discussion"
        },
        {
            "endOffset": 25861,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 25860,
                    "startOffset": 25856
                }
            },
            "secId": "s0020",
            "sentence": "The procedure for preparation of SSF was reported in detail previously [15].",
            "startOffset": 25785,
            "title": "Preparation of antigen-SF-10"
        },
        {
            "endOffset": 24090,
            "parents": [],
            "refoffsets": {
                "b0150": {
                    "endOffset": 23974,
                    "startOffset": 23970
                }
            },
            "secId": "s0005",
            "sentence": "Although these oral influenza vaccines require higher doses of antigen by several orders of magnitude [30], the level of induced immunity was relatively lower than that achieved through nasal and subcutaneous vaccinations.",
            "startOffset": 23868,
            "title": "Introduction"
        },
        {
            "endOffset": 41423,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "No significant induction of HAv-specific IgG in serum and S-IgA in BALF was noted in mice immunized orally with HAv-LPS, -Pam3CSK4, -poly(I:C), -CpG, and -CT-B, compared with immunization using HAv alone.",
            "startOffset": 41219,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 41909,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The induced levels of HAv-specific IgG by HAv-SF-10(p.o.) were 5.5-fold higher in serum and HAv-specific S-IgA were 63-fold higher in BALF, compared with those induced by HAv-CT(p.o.).",
            "startOffset": 41725,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 48790,
            "parents": [],
            "secId": "s0090",
            "sentence": "Vaccination with HAv-SF-10(p.o) elicited HAv-responsive Th1, Th2 and Th17 cytokine-producing cells (Table 2).",
            "startOffset": 48681,
            "title": "Discussion"
        },
        {
            "endOffset": 34156,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Survival rate was analyzed by the Kaplan-Meier and log-rank tests.",
            "startOffset": 34090,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 38950,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Mice were immunized four times with HAv(i.n.), HAv(p.o.), HAv(s.c.), HAv-SF-10(i.n.) and HAv-SF-10(p.o.), and the splenocytes of these mice were isolated at 2 weeks after the last immunization, followed by incubation with or without HAv for 3 days.",
            "startOffset": 38702,
            "title": "Induction of HAv-specific Th1, Th2 and Th17-type immune responses following oral vaccination with HAv-SF-10"
        },
        {
            "endOffset": 31640,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After incubation, the spots of HAv-specific ASCs were detected by goat anti-mouse IgA or anti-mouse IgG antibody conjugated with horseradish peroxidase (Sigma-Aldrich) and 3-amino-9-ethylcarbazole (Sigma-Aldrich).",
            "startOffset": 31427,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 36331,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Administration of HAv alone without SF-10, either intranasally [HAv(i.n.)] or orally [HAv(p.o.)], was associated with very low levels of HAv-specific IgA, S-IgA and IgG in all specimens.",
            "startOffset": 36145,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 34533,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "To assess the effects of SF-10 on antigen uptake into intestinal APCs, mice were orally administrated reporter antigen fOVA and fOVA-SF-10 for 12 h and 24 h, and APCs in the epithelial and lamina propria layers of the small intestine were isolated.",
            "startOffset": 34285,
            "title": "SF-10 increases antigen uptake into intestinal APCs"
        },
        {
            "endOffset": 21336,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 21335,
                    "startOffset": 21331
                }
            },
            "secId": "s0005",
            "sentence": "Furthermore, we recently improved the SSF for large-scale manufacturing and enhancement of its adjuvanticity [12].",
            "startOffset": 21222,
            "title": "Introduction"
        },
        {
            "endOffset": 35360,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "These results indicate that SF-10 adjuvant enhances antigen uptake into APCs in the gastrointestinal mucosa for at least 12 h.",
            "startOffset": 35234,
            "title": "SF-10 increases antigen uptake into intestinal APCs"
        },
        {
            "endOffset": 43821,
            "parents": [],
            "secId": "s0090",
            "sentence": "The present study describes several new findings on pulmonary surfactant mimicking adjuvant SF-10.",
            "startOffset": 43723,
            "title": "Discussion"
        },
        {
            "endOffset": 49335,
            "parents": [],
            "secId": "s0090",
            "sentence": "In the present study, we found markedly high HAv responsive IL-17A production levels in mice vaccinated with HAv-SF-10(p.o.) and HAv-SF-10(i.n.) compared with HAv(p.o.), HAv(i.n.) and HAv(s.c.).",
            "startOffset": 49141,
            "title": "Discussion"
        },
        {
            "endOffset": 33761,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Data were expressed as mean \u00b1 SEM.",
            "startOffset": 33727,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 52228,
            "parents": [],
            "secId": "s0090",
            "sentence": "Although HAv-CT(p.o.) induced HAv-specific IgG in serum with HI titers > 40 (Fig. 4C and 5A), sufficient levels of HAv-specific S-IgA were lacking in BALF and only 20% of the mice were alive after severe influenza virus challenge.",
            "startOffset": 51998,
            "title": "Discussion"
        },
        {
            "endOffset": 53455,
            "parents": [],
            "secId": "s0090",
            "sentence": "To demonstrate the translational values of our new oral vaccine formulation, further studies are required.",
            "startOffset": 53349,
            "title": "Discussion"
        },
        {
            "endOffset": 27933,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Another group of mice was inoculated intranasally with 1 \u03bcg HAv with or without 10 \u03bcg SF-10 in 6 \u03bcL of saline (3 \u03bcL/each nostril) [HAv-SF-10(i.n.)] by using a Eppendorf\u00ae Research\u00ae plus pipette, Z683787 Aldrich or subcutaneously injected with 1 \u03bcg HAv in 100 \u03bcL saline [HAv(s.c.)] by using a 1 mL plastic syringe at days 0, 3, 14, and 17, respectively.",
            "startOffset": 27582,
            "title": "Immunization and sampling of serum and mucosal fluid"
        },
        {
            "endOffset": 36870,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "In contrast, HAv-SF-10(p.o.) was associated with noticeable induction levels of both IgA and IgG in serum at about 20-fold higher than those by HAv-SF-10(i.n.) (Fig. 2A) and S-IgA and IgG in BALF at about 700- and 200-fold higher than those by HAv-SF-10(i.n.), respectively (Fig. 2B).",
            "startOffset": 36586,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 29759,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 29758,
                    "startOffset": 29754
                }
            },
            "secId": "s0035",
            "sentence": "HAv-specific IgA, S-IgA and IgG levels were calculated by using affinity-purified mouse HAv-specific IgA and IgG as standards, as described previously [11].",
            "startOffset": 29603,
            "title": "Measurement of HAv-specific IgA, S-IgA and IgG"
        },
        {
            "endOffset": 36144,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The serum, BALF, nasal washes, and gastric and fecal extracts were prepared at 2 weeks after the last immunization, and the HAv-specific IgA, S-IgA and IgG antibodies of these specimens were measured by ELISA (Fig. 2).",
            "startOffset": 35926,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 44719,
            "parents": [],
            "secId": "s0090",
            "sentence": "iv) Marked induction of both HAv-specific IgA/S-IgA and IgG antibody-producing cells in respiratory and gastrointestinal mucosal lymph nodes of mice immunized with HAv-SF-10(p.o.), compared with mice immunized with HAv(p.o.).",
            "startOffset": 44494,
            "title": "Discussion"
        },
        {
            "endOffset": 36585,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "HAv-SF-10(i.n.) was associated with significantly higher levels of HAv-specific IgA, S-IgA and IgG in all specimens compared with the levels of HAv(i.n.).",
            "startOffset": 36431,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 39347,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "HAv stimulated the induction of all cytokines in each group of immunized mice.",
            "startOffset": 39269,
            "title": "Induction of HAv-specific Th1, Th2 and Th17-type immune responses following oral vaccination with HAv-SF-10"
        },
        {
            "endOffset": 28960,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 28959,
                    "startOffset": 28955
                }
            },
            "secId": "s0030",
            "sentence": "At 12 or 24 h after vaccination, small intestinal mucosal cells were isolated, and the epithelial layer cells and lamina propria layer cells were purified separately by 2 mM EDTA (Nacalai tesque) solution and 1.5 mg/mL collagenase type IV (Gibco, Grand Island, NY) in Ca2+- and Mg2+-free Hank\u2019s balanced salt solution, respectively, as described in detail previously [31].",
            "startOffset": 28588,
            "title": "Measurement of antigen uptake by small intestinal mucosal cells"
        },
        {
            "endOffset": 26314,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "SSF was mixed with HAv or Alexa647-labeled ovalbumin (fOVA, Thermo Fisher Scientific, Middletown, VA) at a SSF phospholipid:antigen protein ratio of 10:1 at 42 \u00b0C, and the stable antigen-SSF complex was prepared by lyophilization and stored at \u221220 \u00b0C until use.",
            "startOffset": 26053,
            "title": "Preparation of antigen-SF-10"
        },
        {
            "endOffset": 38701,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "To analyze the immunological background of high induction levels of HAv-specific IgG and IgA in serum and HAv-specific S-IgA in mucosal fluid of mice vaccinated with HAv-SF-10(p.o.), we measured cytokine induction of HAv-specific Th1, Th2 and Th17-type immune responses of splenocytes.",
            "startOffset": 38416,
            "title": "Induction of HAv-specific Th1, Th2 and Th17-type immune responses following oral vaccination with HAv-SF-10"
        },
        {
            "endOffset": 42854,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "More than 104 PFU/mL of IAV was detected in BALF of mice immunized with carbo-buffer and HAv(p.o.) at days 4 and 7, but only 20 PFU/mL at day 4 and below the detection levels at day 7 were detected in the BALF of mice immunized with HAv-SF-10(p.o.).",
            "startOffset": 42605,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 28202,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The gastric extract was prepared by allowing the stomach to stand in a 2% saponin (Nacalai tesque)-PBS overnight at 4 \u00b0C.",
            "startOffset": 28081,
            "title": "Immunization and sampling of serum and mucosal fluid"
        },
        {
            "endOffset": 26372,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "To prepare 1% CVP (HIVISWAKO104, FUJIFILM Wako Pure Chem.",
            "startOffset": 26315,
            "title": "Preparation of antigen-SF-10"
        },
        {
            "endOffset": 51803,
            "parents": [],
            "secId": "s0090",
            "sentence": "For protection against unexpected outbreaks of emerging infections, it is important to develop effective vaccines that can rapidly induce robust protective immunity.",
            "startOffset": 51638,
            "title": "Discussion"
        },
        {
            "endOffset": 48361,
            "parents": [],
            "secId": "s0090",
            "sentence": "These results suggest that the adjuvanticity of SF-10 is more effective on gastrointestinal mucosa than on nasal mucosa.",
            "startOffset": 48241,
            "title": "Discussion"
        },
        {
            "endOffset": 52585,
            "parents": [],
            "secId": "s0090",
            "sentence": "Our study has certain limitations.",
            "startOffset": 52551,
            "title": "Discussion"
        },
        {
            "endOffset": 22011,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 22010,
                    "startOffset": 22006
                }
            },
            "secId": "s0005",
            "sentence": "Based on these improvements, the manufactured pulmonary surfactant mimicked the synthetic adjuvant, which is useful for ample supply and shows enhanced adjuvanticity, and termed the improved adjuvant compound SF-10 [12].",
            "startOffset": 21791,
            "title": "Introduction"
        },
        {
            "endOffset": 25754,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was approved by the Animal Care Committee of Tokushima University (#T27-109).",
            "startOffset": 25667,
            "title": "Vaccine, virus and animals"
        },
        {
            "endOffset": 29602,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "We used goat anti-mouse IgA and anti-mouse IgG antibody conjugated with horseradish peroxidase (Sigma-Aldrich) as the secondary antibodies.",
            "startOffset": 29463,
            "title": "Measurement of HAv-specific IgA, S-IgA and IgG"
        },
        {
            "endOffset": 30937,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "For detection of HAv-specific ASCs by enzyme-linked immunospot (ELISPOT) assay, the isolated lymphocytes from each organ, except the lung, were incubated for 3 days with 1 \u03bcg/mL R848 (Novus Biologicals, Littleton, CO) and 10 ng/mL rmIL-2 (BioLegend) in complete RPMI (cRPMI) medium (containing 10 mM HEPES, pH 7.2, 1 mM sodium pyruvate, 1% MEM non-essential amino acids solution, 14.3 \u03bcM 2-mercaptoethanol, 10 \u03bcg/mL gentamycin and 10% heat-inactivated fetal bovine serum).",
            "startOffset": 30465,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 39741,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "In contrast, HAv-SF-10(p.o.) and HAv-SF-10(i.n.) vaccinations mainly increased the levels of IFN-\u03b3, IL-2, IL-17A and IL-22, compared with HAv(p.o.) and HAv(i.n.), respectively, and the production levels were higher by HAv-SF-10(p.o.) than by HAv-SF-10(i.n.).",
            "startOffset": 39483,
            "title": "Induction of HAv-specific Th1, Th2 and Th17-type immune responses following oral vaccination with HAv-SF-10"
        },
        {
            "endOffset": 32660,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The treated serum was diluted in 96-well plates, and then 4 HA units of the vaccine antigen and 0.75% of washed chicken red blood cells were added to each well, and incubated for 30 min at room temperature.",
            "startOffset": 32454,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 24923,
            "parents": [],
            "secId": "s0005",
            "sentence": "We also assessed the level of protective immunity induced by oral administration of HAv-SF-10 against severe influenza A virus (IAV) challenge in a mouse model of acute pneumonia.",
            "startOffset": 24744,
            "title": "Introduction"
        },
        {
            "endOffset": 21790,
            "parents": [],
            "secId": "s0005",
            "sentence": "To achieve more efficient antigen delivery activity for SSF, we added carboxy vinyl polymer (CVP) to increase the viscosity of antigen-SSF complex and prolong antigen uptake time on the mucosal surface.",
            "startOffset": 21588,
            "title": "Introduction"
        },
        {
            "endOffset": 31731,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The number of ASC spots was counted by ELISPOT counter ImmunoSpot S6 (CTL, Cleveland, OH).",
            "startOffset": 31641,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 33704,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Another group of BALB/c mice was immunized twice orally with HAv, HAv-SF-10 or HAv-CT at days 0 and 3, and then all mice were infected intranasally with 20 \u03bcL of a lethal dose of IAV/ PR8/34(H1N1) (50 to 1000 PFU), and the survival and body weight loss were monitored during the period of 15 days after infection.",
            "startOffset": 33391,
            "title": "Protection against virus challenge in mice after oral vaccination"
        },
        {
            "endOffset": 45299,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 45298,
                    "startOffset": 45288
                },
                "b0095": {
                    "endOffset": 45298,
                    "startOffset": 45288
                },
                "b0100": {
                    "endOffset": 45298,
                    "startOffset": 45288
                },
                "b0105": {
                    "endOffset": 45298,
                    "startOffset": 45288
                },
                "b0170": {
                    "endOffset": 45298,
                    "startOffset": 45288
                }
            },
            "secId": "s0090",
            "sentence": "The natural pulmonary surfactant, which is secreted from alveolar type II epithelial cells, is absorbed and metabolized rapidly not only in respiratory mucosa but also gastrointestinal mucosa cells [18\u201321,34].",
            "startOffset": 45090,
            "title": "Discussion"
        },
        {
            "endOffset": 37853,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "To confirm the production sites of HAv-specific IgA, S-IgA and IgG in mice vaccinated orally 4 times with HAv or HAv-SF-10, we isolated lymphocytes from the lung, spleen, CLN, MLN, PP and GLN at 2 weeks after the last immunization, and measured the HAv-specific IgA and IgG ASCs by ELISPOT assay.",
            "startOffset": 37557,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 40273,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "To optimize the time of oral vaccination, HAv-SF-10(p.o.) was administered one to four times, as illustrated in Fig. 4A.",
            "startOffset": 40153,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 40398,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The levels of HAv-specific IgG in serum and HAv-specific S-IgA in BALF were measured at 2 weeks after the last immunization.",
            "startOffset": 40274,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 50530,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 50529,
                    "startOffset": 50525
                }
            },
            "secId": "s0090",
            "sentence": "It has been reported that bacterial- or viral-based mucosal adjuvants administrated through the intranasal and oral routes induce both mucosal S-IgA and serum IgG [45].",
            "startOffset": 50362,
            "title": "Discussion"
        },
        {
            "endOffset": 20188,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 20187,
                    "startOffset": 20181
                },
                "b0050": {
                    "endOffset": 20187,
                    "startOffset": 20181
                },
                "b0055": {
                    "endOffset": 20187,
                    "startOffset": 20181
                },
                "b0060": {
                    "endOffset": 20187,
                    "startOffset": 20181
                }
            },
            "secId": "s0005",
            "sentence": "To overcome this shortfall, previous studies investigated the benefits of intranasal mucosal vaccine adjuvant, which can induce both S-IgA in the airway mucosa and IgG in serum [9\u201312].",
            "startOffset": 20004,
            "title": "Introduction"
        },
        {
            "endOffset": 22780,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 22779,
                    "startOffset": 22772
                },
                "b0100": {
                    "endOffset": 22779,
                    "startOffset": 22772
                }
            },
            "secId": "s0005",
            "sentence": "Previous studies indicated a progressive increase in micelles of pulmonary surfactant in human amniotic fluid at term and that the micelles in the amniotic fluid are swallowed by the fetus [19,20].",
            "startOffset": 22583,
            "title": "Introduction"
        },
        {
            "endOffset": 25367,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All animals were maintained under specific-pathogen-free conditions.",
            "startOffset": 25299,
            "title": "Vaccine, virus and animals"
        },
        {
            "endOffset": 21086,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 21085,
                    "startOffset": 21081
                }
            },
            "secId": "s0005",
            "sentence": "Among the various constituents of human pulmonary surfactant, we found three major lipids; 1,2-dipalmitoyl-phosphatidylcholine (DPPC), phosphatidylglycerol (PG), and palmitic acid (PA), together with surfactant protein C (SP-C), to be essential constituents for its mucosal adjuvanticity [15].",
            "startOffset": 20793,
            "title": "Introduction"
        },
        {
            "endOffset": 37280,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The induced levels of HAv-specific S-IgA and IgG in nasal washes (Fig. 2C), gastric extracts (Fig. 2D) and fecal extracts (Fig. 2E) of mice immunized with HAv-SF-10(p.o.) were significantly higher at about 2- to 20-fold and 10- to 50- fold, respectively, than those by HAv-SF-10(i.n.).",
            "startOffset": 36995,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 42604,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Immunized mice were infected with IAV/PR8(H1N1) at a lethal dose of 50 PFU (50 \u00d7 LD50) at 2 weeks after the last immunization and then virus titers in BALF were measured at days 4 and 7 after infection.",
            "startOffset": 42402,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 43096,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "We also monitored the survival rates (Fig. 5C) and changes in body weight (Fig. 5D) of mice immunized with HAv, HAv-CT, or HAv-SF-10 after infection with three lethal doses of IAV/PR8(H1N1) (50, 250, and 1000 \u00d7 LD50) over a period of 15 days.",
            "startOffset": 42854,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 41724,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Among the tested adjuvants derived from bacteria and virus origins, only CT with HAv [HAv-CT(p.o.)] was associated with induction of HAv-specific IgG in serum and very low levels of HAv-specific S-IgA in BALF, but the levels were significantly lower than those of mice immunized with HAv-SF-10(p.o.).",
            "startOffset": 41424,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 47572,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 47571,
                    "startOffset": 47568
                }
            },
            "secId": "s0090",
            "sentence": "In addition, seasonal human influenza virus infects the respiratory mucosa and highly pathogenic avian influenza viruses, such as H5N1, infect both respiratory and gut mucosa [8].",
            "startOffset": 47393,
            "title": "Discussion"
        },
        {
            "endOffset": 29462,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 29461,
                    "startOffset": 29457
                }
            },
            "secId": "s0035",
            "sentence": "Two weeks after the last immunization, we measured HAv-specific IgA and IgG levels in the serum and HAv-specific S-IgA and IgG levels in the mucosal fluid by enzyme-linked immunosorbent assay (ELISA), as described previously [15].",
            "startOffset": 29232,
            "title": "Measurement of HAv-specific IgA, S-IgA and IgG"
        },
        {
            "endOffset": 20271,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 20270,
                    "startOffset": 20263
                },
                "b0065": {
                    "endOffset": 20270,
                    "startOffset": 20263
                }
            },
            "secId": "s0005",
            "sentence": "However, many such vaccines were found ineffective or had safety problems [11,13].",
            "startOffset": 20189,
            "title": "Introduction"
        },
        {
            "endOffset": 26769,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The final solution in the presence of CVP was termed antigen-SF-10.",
            "startOffset": 26702,
            "title": "Preparation of antigen-SF-10"
        },
        {
            "endOffset": 24440,
            "parents": [],
            "secId": "s0005",
            "sentence": "The aim of the present study was to determine the effects of oral administration of HAv-SF-10 into the gastrointestinal tract of mice on respiratory, gastrointestinal and systemic immunity.",
            "startOffset": 24251,
            "title": "Introduction"
        },
        {
            "endOffset": 21221,
            "parents": [],
            "secId": "s0005",
            "sentence": "We also prepared a synthetic surfactant (SSF) of these constituents that mimics the antigen delivery activity of pulmonary surfactant.",
            "startOffset": 21087,
            "title": "Introduction"
        },
        {
            "endOffset": 37557,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The mean HI titers in serum of mice after vaccination 4 times with HAv-SF-10(p.o.) were the highest at 3307 \u00b1 849 among the vaccination groups tested (Table 1): 2.2-fold of HAv(s.c.), 24-fold of HAv-SF-10(i.n.), and those in mice treated with HAv(p.o.) and HAv(i.n.) were < 40.",
            "startOffset": 37280,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 41087,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Mice were immunized twice orally with HAv or HAv-SF-10, -LPS, -Pam3CSK4, -poly(I:C), -CpG, -CT-B, or \u2013CT.",
            "startOffset": 40982,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 43712,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Mice immunized with HAv-SF-10(p.o.) showed rapid recovery of body weight loss following infection with 50 \u00d7 LD50 IAV/PR8(H1N1), but recovery delay was detected after 250 and 1000 \u00d7 LD50 IAV/PR8(H1N1) infection.",
            "startOffset": 43502,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 23448,
            "parents": [],
            "secId": "s0005",
            "sentence": "Accordingly, it is assumed that effective antigen presentation in the gastrointestinal mucosal APCs can be achieved by oral vaccination of antigen-SF-10 complex through the delivery activity of pulmonary surfactant to the gastrointestinal mucosal epithelium.",
            "startOffset": 23190,
            "title": "Introduction"
        },
        {
            "endOffset": 22965,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 22817,
                    "startOffset": 22813
                }
            },
            "secId": "s0005",
            "sentence": "More recently, Nishijima et al. [21] reported that the micelles swallowed by the fetus are absorbed by the intestinal mucosal epithelium where they stimulate villous height maturation.",
            "startOffset": 22781,
            "title": "Introduction"
        },
        {
            "endOffset": 43501,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "In contrast, all mice immunized with HAv-SF-10(p.o.) survived following infection with 50 \u00d7 LD50 IAV/PR8(H1N1) (P = 0.004, vs. HAv(p.o.); P = 0.084, vs. HAv-CT(p.o.)) and also following infection with 250 \u00d7 LD50 and 1000 \u00d7 LD50 IAV/PR8(H1N1).",
            "startOffset": 43259,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 43258,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "All mice that were immunized with HAv(p.o.) died at day 9 after infection with 50 \u00d7 LD50 IAV/PR8(H1N1) and only 20% of mice immunized with HAv-CT(p.o.) survived.",
            "startOffset": 43097,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 45470,
            "parents": [],
            "secId": "s0090",
            "sentence": "The findings suggest that antigen complexed with SF-10 is incorporated efficiently into the gastrointestinal mucosa and APCs and then induces antigen-specific immunities.",
            "startOffset": 45300,
            "title": "Discussion"
        },
        {
            "endOffset": 36430,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "HAv(s.c.) induced only moderate levels of HAv-specific IgG but not S-IgA and IgA in all specimens.",
            "startOffset": 36332,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 50197,
            "parents": [],
            "secId": "s0090",
            "sentence": "Furthermore, immunization with HAv-SF-10(p.o.) induced mild levels of HAv-responsive IL-4 (Table 2), which induces IgE, although marked induction of IL-4 was detected by HAv(s.c.).",
            "startOffset": 50017,
            "title": "Discussion"
        },
        {
            "endOffset": 19138,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 19137,
                    "startOffset": 19134
                }
            },
            "secId": "s0005",
            "sentence": "Influenza virus infects approximately 10\u201320% of the world population annually, causing death of approximately 290,000 to 650,000 individuals [1].",
            "startOffset": 18993,
            "title": "Introduction"
        },
        {
            "endOffset": 31426,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The lymphocytes were then seeded at the indicated number (from 105 to 106 cells/well) onto MultiScreen 96-well plates MSIPS4510 (Millipore), which were pre-coated with 1 \u03bcg HAv protein/well, and incubated with fresh cRPMI for 4 h (lung lymphocytes) or 24 h (excluding lung lymphocytes).",
            "startOffset": 31140,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 24251,
            "parents": [],
            "secId": "s0005",
            "sentence": "In this regard, whereas oral administration of DNA vaccines can reduce vaccine doses, it carries the risk of releasing genetically modified organisms to nature.",
            "startOffset": 24091,
            "title": "Introduction"
        },
        {
            "endOffset": 31993,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "For measurement of cytokine levels secreted by HAv-responsive splenocytes of mice immunized subcutaneously, intranasally or orally with HAv or HAv-SF-10, isolated splenocytes were incubated with cRPMI medium with or without 10 \u03bcg HAv per 106 cells/mL for 3 days.",
            "startOffset": 31731,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 50362,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 50263,
                    "startOffset": 50259
                }
            },
            "secId": "s0090",
            "sentence": "Indeed, HAv(s.c.) vaccination induced HAv-specific serum IgE [12] but the levels of IgE induced by HAv-SF-10(p.o.) were below the detection levels (data not shown).",
            "startOffset": 50198,
            "title": "Discussion"
        },
        {
            "endOffset": 53851,
            "parents": [],
            "secId": "s0090",
            "sentence": "In conclusion, we have demonstrated in the present study that SF-10, which mimics human pulmonary surfactant, is a suitable and effective mucosal adjuvant that can be used for oral route vaccination to provide potent and rapid systemic and mucosal immunity.",
            "startOffset": 53594,
            "title": "Discussion"
        },
        {
            "endOffset": 48906,
            "parents": [],
            "secId": "s0090",
            "sentence": "Th1 and Th2 cells are major subsets of CD4 helper T cells and modulate cellular and humoral immunity, respectively.",
            "startOffset": 48791,
            "title": "Discussion"
        },
        {
            "endOffset": 45089,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 45088,
                    "startOffset": 45084
                }
            },
            "secId": "s0090",
            "sentence": "We reported previously that pulmonary surfactant mimicking SF-10 adjuvant amplifies antigen uptake into mucosal APCs in the nasal cavity and induces humoral and cellular immunities [17].",
            "startOffset": 44903,
            "title": "Discussion"
        },
        {
            "endOffset": 39482,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "HAv(s.c.) vaccination induced both Th1 and Th2 cytokines, and the levels of IL-4 and IL-5 were the highest among the immunized groups.",
            "startOffset": 39348,
            "title": "Induction of HAv-specific Th1, Th2 and Th17-type immune responses following oral vaccination with HAv-SF-10"
        },
        {
            "endOffset": 31139,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The incubated lymphocytes and non-incubated lung lymphocytes isolated from mice immunized orally with HAv or HAv-SF-10 were counted by LUNA-II\u2122 Automated Cell Counter (Logos Biosystems, Anyang, Korea).",
            "startOffset": 30938,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 52799,
            "parents": [],
            "secId": "s0090",
            "sentence": "Oral vaccination shows in generally two reciprocate aspects, immune tolerance induction and protective immunity induction, although details of difference in the mechanisms between them have not been well analyzed.",
            "startOffset": 52586,
            "title": "Discussion"
        },
        {
            "endOffset": 34713,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 34667,
                    "startOffset": 34663
                }
            },
            "secId": "s0065",
            "sentence": "fOVA-labelled MHC II+CD11c+ cells (APCs), and CD11b+CD103+ and CD11b+CD103- DC subtypes, which are the major DC subtypes in APCs [33], were detected by flow cytometry (Fig. 1A-E).",
            "startOffset": 34534,
            "title": "SF-10 increases antigen uptake into intestinal APCs"
        },
        {
            "endOffset": 30165,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Two weeks after the fourth oral vaccination, the spleen, cervical lymph nodes (CLN), mesenteric lymph nodes (MLN), Peyer\u2019s patches (PP), gastric lymph nodes (GLN), and lung lymph nodes were isolated from mice immunized with HAv or HAv-SF-10 in carbo-buffer.",
            "startOffset": 29908,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 42263,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "The induced HI titer of HAv-SF-10(p.o.) was > 160, which was significantly higher than that of HAv-CT(p.o.).",
            "startOffset": 42155,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 42401,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Fig. 5B shows the neutralization activities of BALF in mice immunized with HAv-SF-10(p.o.), HAv(p.o.) and carbo-buffer (negative control).",
            "startOffset": 42263,
            "title": "Protective immunity induced by oral vaccination of HAv-SF-10"
        },
        {
            "endOffset": 40758,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0060": {
                    "endOffset": 40757,
                    "startOffset": 40753
                }
            },
            "secId": "s0080",
            "sentence": "Serum IgG and BALF S-IgA increased exponentially with time of vaccination and serum HAv-specific IgG levels reached about 500 \u03bcg/mL after two times immunization, the levels were almost equivalent to the IgG titers with complete protection against severe IAV infection, which was induced in mice administrated with HAv-SF-10(i.n.), as reported previously [12].",
            "startOffset": 40399,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 48037,
            "parents": [],
            "secId": "s0090",
            "sentence": "Based on the results of this study, we propose that oral administration of HAv-SF-10, which induced higher levels of systemic and mucosal HAv-specific antibodies compared with other vaccination routes (Fig. 2), and also induced HAv-specific ASCs in the respiratory and gastrointestinal mucosal lymphoid tissues (Fig. 3).",
            "startOffset": 47717,
            "title": "Discussion"
        },
        {
            "endOffset": 29183,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "These cells were stained with anti-mouse I-A/I-E (MHC II), CD11b, CD11c and CD103 (BioLegend, San Diego, CA) and analyzed by FACSVerse (BD Biosciences, Franklin Lakes, NJ) and Flowjo software (Tree Star Inc., Ashland, OR).",
            "startOffset": 28961,
            "title": "Measurement of antigen uptake by small intestinal mucosal cells"
        },
        {
            "endOffset": 36994,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Induction of HAv-specific IgG by HAv-SF-10(p.o.) was also significantly higher at about 7-fold that by HAv(s.c.) (Fig. 2A).",
            "startOffset": 36871,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 45649,
            "parents": [],
            "secId": "s0090",
            "sentence": "Indeed, we found that SF-10 enhanced antigen uptake into intestinal APCs, such as CD11b+CD103+ DCs and CD11b+CD103- DCs, the major subsets of intestinal DCs for oral vaccination.",
            "startOffset": 45471,
            "title": "Discussion"
        },
        {
            "endOffset": 32239,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The concentration of IL-2, IL-4, IL-5, IL-17A, IL-21 and IFN-\u03b3 in the culture media supernatant was measured by LEGENDplexTM and analyzed by LEGENDplex\u2122 Data Analysis Software (BioLegend) according to the protocols provided by the manufacturers.",
            "startOffset": 31994,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 25298,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Female BALB/c mice (age 6\u20138 weeks) were purchased from Japan SLC (Shizuoka, Japan).",
            "startOffset": 25215,
            "title": "Vaccine, virus and animals"
        },
        {
            "endOffset": 35036,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The percentages of fOVA-labelled cells among the APCs (Fig. 1F), CD11b+CD103+ DCs (Fig. 1G) and CD11b+CD103- DCs (Fig. 1H) in the epithelial and lamina propria layers indicated that SF-10 significantly increased fOVA-uptake into the intestinal APCs after administration for 12 h, compared with those induced by fOVA alone.",
            "startOffset": 34714,
            "title": "SF-10 increases antigen uptake into intestinal APCs"
        },
        {
            "endOffset": 46139,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 46068,
                    "startOffset": 46064
                },
                "b0190": {
                    "endOffset": 46138,
                    "startOffset": 46134
                }
            },
            "secId": "s0090",
            "sentence": "CD25+Foxp3+ regulatory T cells play an important role in intestinal IgA production [37] and CD11b+CD103+ DCs also induce IgA production in the intestine [38].",
            "startOffset": 45981,
            "title": "Discussion"
        },
        {
            "endOffset": 44903,
            "parents": [],
            "secId": "s0090",
            "sentence": "v) Administration of HAv-SF-10(p.o.) showed unique cytokine induction patterns in the spleen; highest induction of Th17, high induction of Th1 and moderate induction of Th2 cytokines.",
            "startOffset": 44720,
            "title": "Discussion"
        },
        {
            "endOffset": 47716,
            "parents": [],
            "secId": "s0090",
            "sentence": "Thus, it is desirable to induce anti-influenza virus immunities in both the respiratory and gastrointestinal mucosae to prevent such infection.",
            "startOffset": 47573,
            "title": "Discussion"
        },
        {
            "endOffset": 27581,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "38 \u00d7 0.62 mm), connected to a 1 mL plastic syringe, four times vaccination at days 0, 3, 14, and 17 or at the indicated time points of vaccination schedule described in the legends for figures.",
            "startOffset": 27388,
            "title": "Immunization and sampling of serum and mucosal fluid"
        },
        {
            "endOffset": 32804,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The HI endpoint titers represented the reciprocal of the highest serum dilution that produced complete inhibition of hemagglutinating activity.",
            "startOffset": 32661,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 44493,
            "parents": [],
            "secId": "s0090",
            "sentence": "iii) Among the mucosal adjuvants tested in this study, which included adjuvants of microbial origins, SF-10 showed the highest adjuvanticity in gastrointestinal administration route.",
            "startOffset": 44311,
            "title": "Discussion"
        },
        {
            "endOffset": 21587,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 21586,
                    "startOffset": 21582
                }
            },
            "secId": "s0005",
            "sentence": "Since the hydrophobic peptide SP-C does not dissolve in common organic solvents, we selected K6L16 peptide among the SP-C related peptides, as a substitute for human SP-C, which is soluble in methanol and ethanol and expresses high adjuvanticity [12].",
            "startOffset": 21336,
            "title": "Introduction"
        },
        {
            "endOffset": 47392,
            "parents": [],
            "secId": "s0090",
            "sentence": "Subcutaneous or intramuscular vaccination requires needles and syringes, and intranasal vaccination requires spray devices, whereas oral vaccination does not require any special device.",
            "startOffset": 47207,
            "title": "Discussion"
        },
        {
            "endOffset": 19333,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 19255,
                    "startOffset": 19250
                },
                "b0015": {
                    "endOffset": 19255,
                    "startOffset": 19250
                },
                "b0020": {
                    "endOffset": 19255,
                    "startOffset": 19250
                },
                "b0025": {
                    "endOffset": 19255,
                    "startOffset": 19250
                }
            },
            "secId": "s0005",
            "sentence": "Since several types of influenza virus spread globally among humans as well as pets and other domestic animals [2\u20135], there is a need for effective influenza vaccines for both human and animals.",
            "startOffset": 19139,
            "title": "Introduction"
        },
        {
            "endOffset": 45980,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 45861,
                    "startOffset": 45857
                },
                "b0180": {
                    "endOffset": 45979,
                    "startOffset": 45975
                }
            },
            "secId": "s0090",
            "sentence": "Intestinal CD11b+CD103- DCs induce IFN-\u03b3-and IL-17-producing effector T cells [35], and CD11b+CD103+ DCs induce the development of regulatory T cells and control antigen specific immune tolerance [36].",
            "startOffset": 45779,
            "title": "Discussion"
        },
        {
            "endOffset": 51997,
            "parents": [],
            "secId": "s0090",
            "sentence": "Immunization with HAv-SF-10(p.o.) induced potent protective immunity with high HI titers and neutralization activities against severe IAV infection with a short period of time in mice (Fig. 5).",
            "startOffset": 51804,
            "title": "Discussion"
        },
        {
            "endOffset": 20554,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 20553,
                    "startOffset": 20546
                },
                "b0070": {
                    "endOffset": 20553,
                    "startOffset": 20546
                }
            },
            "secId": "s0005",
            "sentence": "We reported previously that pulmonary surfactant, Sufracten\u00ae, was effective and safe intranasal mucosal adjuvant for influenza ether split hemagglutinin vaccine (HAv) and showed potent enhancement of humoral immune responses without adverse reactions in the mouse and swine [11,14].",
            "startOffset": 20272,
            "title": "Introduction"
        },
        {
            "endOffset": 19660,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 19659,
                    "startOffset": 19654
                },
                "b0035": {
                    "endOffset": 19659,
                    "startOffset": 19654
                },
                "b0040": {
                    "endOffset": 19659,
                    "startOffset": 19654
                }
            },
            "secId": "s0005",
            "sentence": "In particular, induction of protective immunity in the respiratory and gastrointestinal mucosae is important for protection against influenza virus infection, because seasonal influenza viruses grow in the respiratory mucosa and the highly pathogenic avian influenza viruses grow in both the respiratory and gut mucosae [6\u20138].",
            "startOffset": 19334,
            "title": "Introduction"
        },
        {
            "endOffset": 50735,
            "parents": [],
            "secId": "s0090",
            "sentence": "In the present study, mice were immunized orally twice with HAv combined with LPS, Pam3CSK4, poly(IC), CpG, CT-B, CT, or SF-10, in order to compare the adjuvanticity of SF-10 with these mucosal adjuvants.",
            "startOffset": 50531,
            "title": "Discussion"
        },
        {
            "endOffset": 40981,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "We next compared the induction efficacy of SF-10 and other mucosal adjuvants on HAv-specific IgG in serum and S-IgA in BALF.",
            "startOffset": 40857,
            "title": "Oral vaccination time schedule and comparison of induction efficacy of HAv-specific IgG in serum and S-IgA in BALF among various mucosal adjuvants"
        },
        {
            "endOffset": 35925,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "To compare the effects of oral vaccination of HAv-SF-10 on the induction of humoral immune responses with other administration routes of vaccination, mice were immunized orally, intranasally and subcutaneously 4 times with the same administration doses of HAv and HAv-SF-10.",
            "startOffset": 35651,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 43943,
            "parents": [],
            "secId": "s0090",
            "sentence": "The findings include i) Administration of antigen-SF-10(p.o.) enhanced antigen uptake into gastrointestinal mucosal APCs.",
            "startOffset": 43822,
            "title": "Discussion"
        },
        {
            "endOffset": 50969,
            "parents": [],
            "secId": "s0090",
            "sentence": "While SF-10 induced both HAv-specific S-IgA in BALF and IgG in serum, CT induced HAv-specific IgG in serum only but not HAv-specific S-IgA in BALF (Fig. 4C).",
            "startOffset": 50812,
            "title": "Discussion"
        },
        {
            "endOffset": 51638,
            "parents": [],
            "secId": "s0090",
            "sentence": "Antigen combined with liposome-like adjuvant SF-10 in carbo-buffer may protect antigen degeneration in the gastrointestinal tract and induce effective systemic and local immunity compared with other mucosal adjuvants tested.",
            "startOffset": 51414,
            "title": "Discussion"
        },
        {
            "endOffset": 45778,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 45777,
                    "startOffset": 45773
                }
            },
            "secId": "s0090",
            "sentence": "These DCs primed with antigen migrate from the intestinal lamina propria to MLN and present antigen information to T cells [33].",
            "startOffset": 45650,
            "title": "Discussion"
        },
        {
            "endOffset": 38107,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Both HAv-specific IgA and IgG ASCs were detected in all lymphocytes of lung, spleen, CLN, MLN, PP and GLN of mice immunized with HAv-SF-10(p.o.), but not those immunized with HAv(p.o.) alone, except detection of few IgG spots in CLN and spleen (Fig. 3).",
            "startOffset": 37854,
            "title": "Oral vaccination of HAv-SF-10 induces higher levels of HAv-specific IgA and IgG levels in serum and HAv-specific S-IgA and IgG in various mucosal fluids compared with nasal and subcutaneous vaccination and increases HAv-specific IgA and IgG ASCs in various lymph nodes throughout the body"
        },
        {
            "endOffset": 49140,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 49139,
                    "startOffset": 49132
                },
                "b0085": {
                    "endOffset": 49139,
                    "startOffset": 49132
                }
            },
            "secId": "s0090",
            "sentence": "In our previous study, immunization using HAv-SF-10(i.n.) elicited HAv-responsive Th1 type cytokine- (IFN-\u03b3), and Th2 type cytokine (IL-4)-producing lymphocytes and induced antigen specific humoral and cell mediated immunity [12,17].",
            "startOffset": 48907,
            "title": "Discussion"
        },
        {
            "endOffset": 20003,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 19833,
                    "startOffset": 19830
                }
            },
            "secId": "s0005",
            "sentence": "The currently available influenza vaccines administered intramuscularly or subcutaneously induce a predominant IgG-mediated protection in the systemic immune compartment [9], but hardly induce adequate production of antiviral secretory IgA (S-IgA) for protection against infection in the airway mucosa, the site of viral entry and propagation.",
            "startOffset": 19660,
            "title": "Introduction"
        },
        {
            "endOffset": 35233,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "However, the percentages of fOVA-labelled cells in APCs were markedly decreased after administration for 24 h and no significant differences were detected between fOVA and fOVA-SF-10 treated mice.",
            "startOffset": 35037,
            "title": "SF-10 increases antigen uptake into intestinal APCs"
        },
        {
            "endOffset": 47206,
            "parents": [],
            "secId": "s0090",
            "sentence": "To develop an effective influenza vaccination, a simple and easy inoculation method for mass vaccination is required.",
            "startOffset": 47089,
            "title": "Discussion"
        },
        {
            "endOffset": 44158,
            "parents": [],
            "secId": "s0090",
            "sentence": "ii) Vaccination with HAv-SF-10(p.o.) induced systemic and local HAv-specific antibodies in serum and various mucosal fluids, respectively, higher than those by HAv(s.c.), HAv-SF-10(i.n.) and HAv(p.o.) vaccinations.",
            "startOffset": 43944,
            "title": "Discussion"
        },
        {
            "endOffset": 48681,
            "parents": [],
            "secId": "s0090",
            "sentence": "In addition, the high levels of HAv-specific S-IgA in the gastrointestinal tract (Fig. 2D and E) and high amounts of HAv-specific ASCs in PP and MLN (Fig. 3D and E) of mice immunized with HAv-SF-10(p.o.), suggest that oral administration of HAv-SF-10 is potentially suitable for prevention of influenza virus infection.",
            "startOffset": 48362,
            "title": "Discussion"
        },
        {
            "endOffset": 24743,
            "parents": [],
            "secId": "s0005",
            "sentence": "For this purpose, we analyzed the induction of HAv-specific antibody secreting cells (ASCs) in the respiratory and gut organ-associated lymphoid tissues, and the levels of cytokines secreted by HAv responsive helper T cells in the spleen of immunized mice to evaluate the Th1/Th2/Th17 immunity balance.",
            "startOffset": 24441,
            "title": "Introduction"
        },
        {
            "endOffset": 34223,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "P values less than 0.05 were considered statistically significant.",
            "startOffset": 34157,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 26506,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Co., Osaka, Japan) solution, CVP powder was dissolved in saline by stirring followed by sonication and then stored at 4 \u00b0C until use.",
            "startOffset": 26373,
            "title": "Preparation of antigen-SF-10"
        },
        {
            "endOffset": 33183,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "To assess the efficacy of protective immunity after oral vaccination, BALB/c mice were immunized twice orally with HAv, HAv-SF-10 or carbo-buffer at days 0 and 3, and then all mice were infected intranasally with 20 \u03bcL of IAV/ PR8/34(H1N1) at a dose of 50 \u00d7 LD50 (50 PFU) at 14 days after the last immunization.",
            "startOffset": 32872,
            "title": "Protection against virus challenge in mice after oral vaccination"
        },
        {
            "endOffset": 51413,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 51412,
                    "startOffset": 51408
                }
            },
            "secId": "s0090",
            "sentence": "To improve antigen stability in gastrointestinal tracts, polymerized liposomes which are susceptible to be uptaken by Peyer\u2019s patches and provide superior protection against antigen degeneration have been reported [46].",
            "startOffset": 51194,
            "title": "Discussion"
        },
        {
            "endOffset": 51193,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 51192,
                    "startOffset": 51188
                }
            },
            "secId": "s0090",
            "sentence": "In general, the antigenicity of proteins administered orally degenerates in the low gastric pH environment and digestive enzymes in the gastrointestinal tract, making it difficult to induce effective oral immunization [40].",
            "startOffset": 50970,
            "title": "Discussion"
        },
        {
            "endOffset": 53348,
            "parents": [],
            "secId": "s0090",
            "sentence": "In addition, we suggested that protective immunity induced by HAv-SF-10(p.o.) is associated with the marked induction of Th17 cytokines, high induction of Th1 cytokines and moderate induction of Th2 cytokines, although the negative issues of Th17-mediated immune responses, such as hyperresponsiveness and inflammatory stimulation in the pathogenesis of viral infection [43.44], have not been studied yet.",
            "startOffset": 52943,
            "title": "Discussion"
        },
        {
            "endOffset": 26052,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Briefly, SSF was prepared by mixing three major lipids of pulmonary surfactant, DPPC, PG and PA, and a cationic hydrophobic peptide K6L16, which mimics SP-C, at a weight ratio of 75:25:10:2.",
            "startOffset": 25862,
            "title": "Preparation of antigen-SF-10"
        },
        {
            "endOffset": 30465,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 30464,
                    "startOffset": 30460
                }
            },
            "secId": "s0040",
            "sentence": "The lymphocytes from the spleen, CLN, PP, MLN, and GLN were purified according to the method described previously [17] while those from lung were purified by collagenase digestion followed by Percoll (GE Healthcare, Buckinghamshire, UK) density gradient centrifugation, as described previously [17].",
            "startOffset": 30166,
            "title": "Detection of HAv-specific antibody secreting cells in lymph nodes by ELISPOT assay and measurement of HAv responsive cytokine levels in the spleen"
        },
        {
            "endOffset": 48240,
            "parents": [],
            "secId": "s0090",
            "sentence": "Notably, the induced levels of HAv-specific serum IgG and BALF S-IgA and HI titers by HAv-SF-10(p.o.) were strikingly higher than those induced by HAv-SF-10(i.n.) and HAv(s.c.) (Fig. 2A and B, Table 1).",
            "startOffset": 48038,
            "title": "Discussion"
        },
        {
            "endOffset": 25214,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "IAV/ PR8/34(H1N1) was provided by The Research Foundation for Microbial Diseases of Osaka University (Kagawa, Japan).",
            "startOffset": 25097,
            "title": "Vaccine, virus and animals"
        },
        {
            "endOffset": 44310,
            "parents": [],
            "secId": "s0090",
            "sentence": "HI titers and protective immunity induced by HAv-SF-10(p.o.) against severe influenza A virus infection were higher than those induced by HAv-CT(p.o.).",
            "startOffset": 44159,
            "title": "Discussion"
        },
        {
            "endOffset": 32359,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 32358,
                    "startOffset": 32354
                }
            },
            "secId": "s0045",
            "sentence": "Hemagglutination inhibition (HI) activity was measured as described previously [14].",
            "startOffset": 32275,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 49502,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 49426,
                    "startOffset": 49422
                },
                "b0210": {
                    "endOffset": 49501,
                    "startOffset": 49497
                }
            },
            "secId": "s0090",
            "sentence": "Recently, Th17, a new subset of T helper cells, was found to produce IL-17A and IL-22 [41] and was related to the development of antigen-specific IgA ASCs in PP [42].",
            "startOffset": 49336,
            "title": "Discussion"
        },
        {
            "endOffset": 40004,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "These results indicate that HAv-SF-10(p.o.) vaccination markedly increases Th1 and Th17 cytokine production with moderate Th2 cytokine induction, whereas Th17 cytokine induction by HAv-SF-10(p.o.), in particular, is the highest among the immunized groups tested.",
            "startOffset": 39742,
            "title": "Induction of HAv-specific Th1, Th2 and Th17-type immune responses following oral vaccination with HAv-SF-10"
        },
        {
            "endOffset": 49624,
            "parents": [],
            "secId": "s0090",
            "sentence": "SF-10 enhanced antigen uptake into intestinal CD11b+CD103- DCs (Fig. 1), which induced IL-17A producing effector T cells.",
            "startOffset": 49503,
            "title": "Discussion"
        },
        {
            "endOffset": 25524,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Mice were anesthetized by intraperitoneal injection of 62.6 mg ketamine and 12.4 mg xylazine per kg body weight before vaccine administration and infection.",
            "startOffset": 25368,
            "title": "Vaccine, virus and animals"
        },
        {
            "endOffset": 53594,
            "parents": [],
            "secId": "s0090",
            "sentence": "We are planning to clarify these limitations described above and cell-mediated immunity by HAv-SF-10(p.o.) in mice and non-human primates.",
            "startOffset": 53456,
            "title": "Discussion"
        },
        {
            "endOffset": 39268,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "In the absence of HAv in the culture medium, no significant induction of cytokines was detected compared with those of no-treatment control in all the vaccination groups.",
            "startOffset": 39098,
            "title": "Induction of HAv-specific Th1, Th2 and Th17-type immune responses following oral vaccination with HAv-SF-10"
        },
        {
            "endOffset": 39097,
            "parents": [
                {
                    "id": "s0060",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The HAv responsive Th1 (IL-2 and IFN-\u03b3), Th2 (IL-4 and IL-5) and Th17 (IL-17A and IL-22) cytokine levels in culture media were measured (Table 2).",
            "startOffset": 38951,
            "title": "Induction of HAv-specific Th1, Th2 and Th17-type immune responses following oral vaccination with HAv-SF-10"
        },
        {
            "endOffset": 28587,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Mice were orally administrated of 100 \u03bcg fOVA with or without SF-10.",
            "startOffset": 28519,
            "title": "Measurement of antigen uptake by small intestinal mucosal cells"
        },
        {
            "endOffset": 50811,
            "parents": [],
            "secId": "s0090",
            "sentence": "All adjuvants other than CT and SF-10 exhibited little or no adjuvanticity.",
            "startOffset": 50736,
            "title": "Discussion"
        },
        {
            "endOffset": 25096,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Split product of HAv of IAV/California/7/2009(H1N1) was purchased from Kitasato Daiichi Sankyo Vaccine Co. (Tokyo, Japan).",
            "startOffset": 24974,
            "title": "Vaccine, virus and animals"
        }
    ],
    "docId": "S0264410X18316475",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Takashi",
                "initial": "T.",
                "last": "Kimoto"
            },
            {
                "email": null,
                "first": "Hyejin",
                "initial": "H.",
                "last": "Kim"
            },
            {
                "email": null,
                "first": "Satoko",
                "initial": "S.",
                "last": "Sakai"
            },
            {
                "email": null,
                "first": "Etsuhisa",
                "initial": "E.",
                "last": "Takahashi"
            },
            {
                "email": "kido@tokushima-u.ac.jp",
                "first": "Hiroshi",
                "initial": "H.",
                "last": "Kido"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.12.002",
        "firstpage": "612",
        "issn": "0264410X",
        "keywords": [
            "Gastrointestinal immunity",
            "Influenza vaccine",
            "Oral vaccination",
            "Pulmonary surfactant",
            "Synthetic mucosal adjuvant",
            "Th17 cytokine"
        ],
        "lastpage": "622",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice"
    }
}